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Actomyosin contractility in epithelial cells is a major force driving changes in tissue 
shape. Biochemical signaling pathways downstream of RhoA control actin assembly 
in conjunction with non-muscle myosin II recruitment and phosphorylation, thus 
playing an important role in regulating actomyosin contractility. In recent years 
evidence for the critical role physical forces play in regulating vital aspects of cell 
behavior, from differentiation to apoptosis, has been piling. External mechanical 
forces have been shown to impact RhoA activity and cellular contractility. Yet, a 
large gap remains in our understanding of how cells translate physical forces into 
biochemical signals to promote mechanoresponses. 
 
During C. elegans ovulation, a single oocyte is propelled into a myoepithelial pouch 
termed the spermatheca. Upon fertilization of the oocyte, actomyosin contractility 
drives spermathecal constriction and facilitates the exit of the newly fertilized embryo 
into the uterus. During each ovulation cycle, entry of the oocyte into the spermatheca 
mechanically stretches the spermathecal cells. In this study, we utilize the intrinsic 
ability the C. elegans reproductive system to induce mechanical force in a cyclical 
manner to investigate RhoA activation downstream of mechanical stimuli in an in 
vivo setting.  
 
Using a reverse genetics RNAi screen, we identified SPV-1 (a RhoGAP protein) and 
RHGF-1 (a RhoGEF protein) to be essential for the precise regulation of spermathecal 
contractility. SPV-1 functions to transduce physical cues from the membrane into a 
biochemical signal controlling contractility by transiently localizing to the apical 
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membrane of the spermatheca. SPV-1 localizes through its F-BAR domain to the 
membrane of the relaxed spermatheca, where it inhibits RHO-1/RhoA activity 
through its RhoGAP domain. Oocyte entry forces the spermatheca cells to stretch and 
as a consequence SPV-1 detaches from the membrane. RHGF-1 plays the opposite 
role by activating RHO-1 through its RhoGEF domain. The increase in RHO-1 
activity facilitates spermatheca contraction and expulsion of the newly fertilized 
embryo into the uterus. This leads to re-formation of membrane folds in the collapsed 
spermatheca, SPV-1 reattachment to the membrane, and initiation of a new cycle. 
 
Our results demonstrate how membrane curvature-dependent localization of an F-
BAR domain coupled to a RhoGAP domain and the antagonistic function between a 
RhoGAP and RhoGEF protein can provide feedback between a mechanical signal and 
actomyosin contractility. We anticipate this to be a widely utilized feedback 
mechanism to balance actomyosin forces based on membrane topology both in the 
face of externally applied forces, as well as in situations when cells apply intrinsic 
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Actomyosin contractility is a universal mechanism to organize cell shape changes in a 
plethora of cellular processes from cell migration and cytokinesis to morphogenic 
events in organisms (as reviewed in Zaidel-Bar et al. (2015)). Local activation of the 
small GTPase RhoA plays a major role in regulating contractility through promoting 
actin polymerization by diaphanous formins (Watanabe et al., 1999) and 
phosphorylation of myosin II regulatory light chain (MLC) by the serine/threonine 
Rho kinase (ROCK) (Amano et al., 1996). In the smooth muscle cells of epithelial 
tubes such as blood vessels and the airway, misregulation of the constriction events is 
the hallmark of various pathological diseases such as vascular hypertension and 
asthma (Chiba and Misawa, 2004; Loirand and Pacaud, 2010).  
 
Cells are capable of sensing physical cues such as shear stress, tension, substrate 
stiffness and changes in cell geometry and respond through co-arrangements of actin 
and myosin to facilitate cell shape change. In some cases, mechanical forces arising 
internally or from external perturbations have been shown modulate contractility by 
regulating the activity of RhoA (as reviewed in Lessey et al. (2012)). The mechanism 
behind the ‘mechanosensing’ ability of cells has been an area of active research in the 
past decade.  Although the signaling pathways downstream of RhoA are well 
characterized (Fukata et al., 2001; Van Eyk et al., 1998), the biomechanical regulation 
of RhoA activation is less well understood.   
 
In this study, we aim to elucidate the mechanosensory pathways linking exogenous 
force to RhoA regulation. Much of the current understanding on how mechanical 
stimuli lead to RhoA activation is derived from in vitro or mammalian cell-based 
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studies whereby experimentally applied forces were designed to mimic, but might not 
fully capture, the physiological condition in vivo (Abiko et al., 2015; Guilluy et al., 
2011; Lessey et al., 2012; Lessey-Morillon et al., 2014). Here, we introduce the use of 
the Caenorhabditis elegans reproduction system as a model to investigate the in vivo 
regulation of RhoA by mechanical stretching of cells. The C. elegans spermatheca, a 
myoepithelial tube, is subjected to external forces during every embryo transit cycle 
(Kovacevic and Cram, 2010). Entry of the oocyte serves as a trigger by stretching of 
the spermathecal cells without the need for experimental manipulation of force.  
Further understanding of the pathways involved in stretch-mediated RhoA activation 
may provide insights into novel drug targets in combating various human diseases 





1.1. RhoA as a molecular switch regulating actomyosin contractility 
The small GTPase RhoA is a central regulator of actomyosin-mediated contractility. 
RhoA is responsible for the generation of contractile forces within the cell by 
regulating the activity of myosin II (Chrzanowska-Wodnicka and Burridge, 1996) and 
formation of actin stress fibers (Watanabe et al., 1999) (Figure 1). Actin filament 
polymerization is facilitated by the actin nucleator and elongation factor Dia1, which 
is under the regulation of RhoA (Watanabe et al., 1999). On the other hand, the other 
direct effector of RhoA, Rho-kinase (ROCK), promotes myosin II activity by direct 
phosphorylation and activation of myosin light chain (MLC) (Amano et al., 1996) 
and/or inhibiting the function of MLC phosphatase to dephosphorylate MLC (Kimura 
et al., 1996). Together, these result in the generation of contractile forces at specific 
locations within the cell. 
 
Although RhoA is ubiquitously expressed in the cell, precise local activation of RhoA 
is essential for the regulation of a specific cellular process. Using a Förster resonance 
energy transfer (FRET)-based biosensor, Pertz and colleagues showed that in 
migrating cells, active RhoA is concentrated at the edges of protrusions (Pertz et al., 
2006). Hence, a higher level of regulation is required for spatial and temporal control 
of RhoA activity. This is achieved by three groups of proteins: 1) RhoGTPase 
activating proteins (RhoGAPs), 2) RhoGTPase guanine nucleotide exchange factors 
(RhoGEFs) and 3) RhoGTPase guanine nucleotide dissociation inhibitors (RhoGDIs) 
(Jaffe and Hall, 2005) (Figure 2). RhoA shuttles between the active GTP-bound and 
inactive GDP-bound forms. The RhoGAP family of proteins serve as a negative 
regulator of Rho activity by enhancing the enzymatic hydrolysis of GTP to GDP 
(Bernards and Settleman, 2004). On the contrary, RhoGEFs catalyze the exchange of 
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GDP with GTP thus promoting RhoA activation (Rossman et al., 2005). The GDI 
anchor proteins function to bind and sequester the inactive pool of RhoA in the 
cytoplasm (Garcia-Mata et al., 2011) while active RhoA is localized at the plasma 
membrane (Adamson et al., 1992; Lang et al., 1993).  
 
The small GTPase RhoA is responsible for a myriad of cellular activities and its 
regulation is essential for proper cell function. At the organism level, mice with 
conditional knockout of the RhoA gene in the epidermis revealed reduced 
contractility and impairment in directed migration of keratinotyes (Jackson et al., 
2011) while deletion of RhoA in the cerebral cortex of developing mice embryos 
resulted in destabilization of the actin and microtubule cytoskeleton in radial glial 
cells (Cappello et al., 2012). RhoA has been reported to be responsive to mechanical 
cues such as shear stress, intercellular tension and substrate stiffness (as reviewed in 
Lessey et al. (2012)). However, the mechanism behind regulation of RhoA activity in 










Figure 2: Schematic of the regulation of RhoA activity. 




1.2. C. elegans spermatheca as a model to study force-induced activation of 
RhoA 
 
The Caenorhabditis elegans belongs to the phylum nematode, commonly known as 
the roundworm. Figure 3 depicts the anatomy of a hermaphrodite worm showing a 
cylindrical, unsegmented outer cuticle layer over the hypodermis. The basic anatomy 
of C. elegans includes the pharynx, intestine, gonad and nervous system. The 
hermaphrodite worm produces both sperm and oocytes in two symmetrical U-shaped 
gonad arms (Figure 4). The sperm is stored in a myoepithelial accordion-like structure 
termed the spermatheca while the mature oocytes are enveloped in the ovarian sheath. 
The spermatheca consists of 24 cells and is highly analogous to epithelial tubes in 
mammals such as the airway, blood vessels and salivary glands. Some common 
features between the spermatheca and tubular epithelial organs include the presence 
of cell-cell contacts, apico-basal polarity and a basally located basement membrane 
(Andrew and Ewald, 2010; Kovacevic and Cram, 2013; Lints and Hall, 2005).  
 
During C. elegans ovulation, the oocyte in closest proximity to the spermatheca is 
stimulated by the major sperm protein (MSP) and undergoes maturation (Miller et al., 
2001). During maturation, the nuclear envelop breaks down and the oocyte undergoes 
cortical rearrangement, transforming from a cylindrical to ovoid.  Biochemical signals 
from MSP and the mature oocyte itself triggers sheath contraction and dilation of the 
distal (in proximity with the oocyte) end of the spermatheca (McCarter et al., 1999). 
The ovulation takes place when the spermatheca is pulled by the contracting sheath to 
envelope the most proximal oocyte. Fertilization of the oocyte happens immediately 
upon ovulation. The newly fertilized embryo resides in the spermatheca for several 
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minutes before initiation of spermathecal constriction and opening of the 
spermatheca-uterine (sp-ut) valve ushers the single-cell embryo into the uterus.   
 
The morphology of the spermatheca undergoes dramatic changes during embryo 
transit. A spermatheca devoid of the oocyte takes the appearance of a deflated pouch 
with a collapsed lumen (Figure 5A, left panel). Images captured with transmission 
electron microscopy (TEM) revealed a convoluted membrane surface of the 
spermathecal cells (Figure 5B, arrows). Entry of an oocyte into the spermatheca leads 
to an expansion of the pouch, resulting in stretching of the spermathecal cells (Figure 
5A, right panel). To facilitate embryo exit, the distal end of the spermatheca constricts 
in a unidirectional manner and pushes the newly fertilized embryo into the uterus. 
Post-embryo transit, the spermatheca collapses and awaits the next ovulation event. 
Precise regulation of the cyclical expansion and constriction of the spermatheca is 
essential for worm fertility. Overconstriction of the spermatheca leads to severing of 
the embryos, while lack of constriction results in embryos being trapped in the 
spermatheca, both resulting in embryonic lethality (Bui and Sternberg, 2002; Kariya 
et al., 2004; Kovacevic and Cram, 2010; Kovacevic et al., 2013; Wissmann et al., 
1999).   
 
Biochemical signaling involving the inositol 1,4,5-triphosphate (IP3)-mediated 
calcium release pathway is essential for contractility of smooth muscle cells. 
Phospholipase C (PLC) is involved in the catalyzing the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) present on the plasma membrane to 
second messangers IP3 and diacylglycerol (DAG) (Berridge and Irvine, 1989). IP3 
then binds to the IP3 receptor on the endoplasmic reticulum (ER) membrane to 
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stimulate calcium release (Clandinin et al., 1998). Calcium, together with calmodulin, 
positively regulates myosin light chain kinase (MLCK) to phosphorylate and activate 
myosin light chain (Rodger, 1992). In the spermatheca, knockdown and loss-of-
function mutations in PLC-1 and ITR-1 (IP3 receptor) revealed trapping of embryos in 
the spermatheca(Bui and Sternberg, 2002; Clandinin et al., 1998; Kariya et al., 2004; 
Kovacevic et al., 2013). Kovercic et. al. recently reported a unidirectional calcium 
wave in the spermatheca is initiated during oocyte entry travelling from the distal to 
proximal direction (Kovacevic et al., 2013) and this wave pattern was disrupted in 
mutants of the calcium signaling pathway.  
 
In conjunction, precise regulation of spermathecal contractility is also dependent on 
the balance between LET-502/Rho-kinase and MEL-11/myosin light chain 
phosphatase (MLCP) (Wissmann et al., 1999). Although the molecular players have 
been well characterized, it is still unclear how the temporal control of spermathecal 
constriction is achieved. Furthermore, although LET-502, a direct downstream 
effector of RHO-1/RhoA, the contribution of RHO-1 in the spermatheca is currently 
unknown. In this study, we utilize the intrinsic ability of the C. elegans reproduction 
cycle to investigate the mechanism behind force-mediated regulation of a contractile 





Reproduced with permission from Wormatlas (http://www.wormatlas.org).  




Figure 4: Illustration of the reproductive system of the C. elegans 
hermaphrodite. 







Figure 5: Changes in spermatheca morphology during embryos transit. 
(A) DIC images showing a sagittal view the spermatheca in the absence and presence 
of an embryo. Oo: oocyte, Sp: spermatheca, Emb: embryo. Scale bar = 20 μm. 
Reproduced with permission from Tan and Zaidel-Bar (2015). 
(B) TEM images of a transverse section of the spermatheca showing highly 





                                                        
1 The image is credited to Nichol Thomson and John White, MRC/LMB. 
We also thank Drs. John White and Jonathan Hodgkin for allowing their archive of C. elegans TEM 
images to be transferred from MRC/LMB, Cambridge, England to the laboratory of Dr. David Hall, 
Albert Einstein College of Medicine, New York for long term curation. 
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1.3. Possible mechanisms for transduction of mechanical force to biochemical 
signals 
 
All cells are subjected to mechanical force, whether forces are applied exogenously 
from the environment or internally generated by the actomyosin contractile apparatus. 
To adapt to the ever-changing environment, cells have evolved the ability to sense 
and respond to these forces. For example, fibroblast cells plated on 3D collagen 
matrices take on the appearance of a network of dendritic extension while cells plated 
on collagen-coated cover slips are well spread with prominent actin stress fibers 
(Grinnell et al., 2003). In recent years, there has been a rapid increase in the 
knowledge of the mechanisms by which cells respond to these forces. Signaling 
pathways involving tyrosine phosphatases, ion channels and GTPases have been 
identified to be initiated in response to mechanical stimuli (as reviewed in Vogel and 
Sheetz (2006)). The receptor-like tyrosine phosphatase α (RPTPα) has been shown to 
be required for force-dependent reinforcement of integrin–cytoskeleton linkages (von 
Wichert et al., 2003). Cell-generated traction forces mediates the opening of a 
mechanically-gate ion channel, Piezo1, to elicit transient Ca2+ influx to direct lineage 
choice in human neuronal stem cell differentiation (Pathak et al., 2014). The small 
GTPase Rac is inactivated in vascular smooth muscle cells and fibroblasts during 
equibiaxial stretch, resulting in the in the loss of lamellipodia and membrane ruffling 
(Katsumi et al., 2002). 
 
External forces applied on cells through various methods such as tensile stress, shear 
stress, compression and experimental tether force have been reported to result in 
elevated RhoA activity (Lessey et al., 2012). RhoGAPs and RhoGEFs are the direct 
upstream regulators of RhoA activity; hence their intracellular localization could 
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greatly impact the pool of active of RhoA. Indeed, studies have reported the 
recruitment of RhoGAPs and RhoGEFs to sites of integrin- and cadherin-based 
adhesions in response to mechanical force (Abiko et al., 2015; Guilluy et al., 2011; 
Lessey-Morillon et al., 2014; Yang et al., 2011). However, the underlying mechanism 
behind the spatially and temporally coordinated translocation of the RhoGAPs and 
RhoGEFs in response to mechanical stimuli is not well understood. To the best of our 
knowledge, there have been no reports on RhoGEFs and RhoGAPs acting as ON and 
OFF switches in a molecular circuit to oscillate RhoA activity in a cyclical contractile 
tube setting. Here, we propose two, possibly coexisting, mechanisms which could link 




1.3.1. BAR-domain proteins as sensors of membrane curvature 
 
The BIN/Amphiphysin/RVS (BAR) superfamily of protein domains is well known for 
its ability to remodel and tubulate the plasma membrane during clathrin-mediated 
endocytosis (Mim and Unger, 2012; Rao et al., 2010). There are several subfamilies 
of BAR domain proteins: classical BAR, Fes/CIP-4 homology-BAR (F-BAR), N-
terminal amphipathic helix-BAR (N-BAR), Inverse-BAR (I-BAR), BAR-pleckstrin 
homology (BAR-PH) and PhoX-BAR (PX-BAR) (Frost et al., 2009). The various 
subfamilies of BAR domains form dimers with distinct crescent-shaped features that 
differ in the degree of their curvature. A high density of positive charge is found in 
their membrane-interacting surface to facilitate binding to the negatively-charged 
plasma membrane (McMahon and Gallop, 2005). Most of the BAR subfamily 
domains are associated with positive membrane curvature with the exception of I-
BAR, which binds to negatively curved membranes (Heath and Insall, 2008; 
Qualmann et al., 2011; Zhao et al., 2011).  
 
An intriguing hypothesis introduced by Peter and colleagues described the sensitivity 
of BAR domains to membrane curvature. They postulated BAR domains to bind with 
higher affinity towards curved membrane compared to flat membrane, thus acting as a 
sensor of membrane curvature (Peter et al., 2004). The curvature-sensing ability of 
BAR domains presents a mechanism for spatial and temporal regulation of protein 
compartmentalization, and function of BAR-domain containing proteins. A study on 
an N-BAR containing protein, Nesprin, successfully demonstrated the ability of BAR 
domain proteins to sense and be recruited to the plasma membrane when there was a 
change in the membrane curvature. The team reported accumulation of Nesprin at 
sites of high membrane curvature when cells were plated on a nanopatterned surface 
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with bumps or at sites of actin polymerization and membrane protrusion (Galic et al., 
2012). BAR domains frequently coexist with other functional domains such as GAPs 
and GEFs (Peter et al., 2004). During events of mechanical stretching, the nanoscopic 
curves on the plasma membrane will be smoothed out. We hypothesize that the BAR 
domain could function as a mechanical sensor of membrane curvature for proper 




1.3.2. Cell-matrix and cell-cell junctions as sites of mechanotransduction 
 
Integrin-based cell-matrix adhesions constitute major sites of mechanotransduction 
(Chen et al., 2004; Geiger et al., 2009) capable of modulating RhoA activity possibly 
through recruitment of RhoGAPs and RhoGEFs. Tension force applied to integrins 
using fibronectin-coated beads induced the recruitment of RhoGEFs GEF-H1 and 
LARG to focal adhesions (Guilluy et al., 2011). Furthermore, p190RhoGAP which is 
associated with endothelial cell-ECM adhesion, is regulated in a biphasic pattern in 
response to shear stress (Yang et al., 2011). Some preliminary findings indicate that 
similar response could be replicated at the adherens junctions. Nelson and colleagues 
have demonstrated that tension force on vascular endothelial (VE)-cadherin junctions 
led to elevated RhoA activity (Nelson et al., 2004). Recently, a RhoGEF, Solo, was 
identified to play a role in VE-cadherin-mediated RhoA activation during cyclic-
stretch-induced reorientation of endothelial cells (Abiko et al., 2015). In C. 
elegans,the presence of β-integrin ortholog PAT-3 and adherens junctions have been 
observed in the spermatheca (Kovacevic and Cram, 2010; Lints and Hall, 2005). We 
seek to identify upstream regulators of RHO-1/RhoA that are activated in response to 












2. Materials and Methods 
 
2.1. C. elegans strains and growth conditions 
Worm strains were grown on nematode growth medium (NGM) agar seeded with 
OP50 Escherichia coli.  Strains were grown at 20° C unless otherwise stated.  All 
worm strains used in this study are listed in Table 1.  Mutant allele of spv-1 (ok1498) 
purchased from the Caenorhabditis Genetics Centre (CGC) was outcrossed two times 





Table 1: Worm strains used in this study. 
Strain Genotype 
N2 Wild-type Bristol 
RZB25 spv-1(ok1498) II outcrossed 2x 
RZB23 spv-1(ok1498) II; msnEx23 [spv-1p::spv-1::GFP+pRF4(rol-6(su1006))]  
RZB145 
spv-1(ok1498) II; msnEx145 [sth-1p::spv-1::GFP+pRF4(rol-
6(su1006))]  
RZB171 msnEx171 [sth-1p::AHPH::GFP+pRF4(rol-6(su1006))]  
RZB173 
spv-1(ok1498) II; msnEx173 [sth-1p::AHPH::GFP+pRF4(rol-
6(su1006))]  
RZB107 
spv-1(ok1498) II; msnEx107 [spv-1p::spv-1(R635K)::GFP+pRF4(rol-
6(su1006))]  
RZB35 
spv-1(ok1498) II; msnEx35 [spv-1p::spv-1ΔRhoGAP::GFP+pRF4(rol-
6(su1006))]  
HR863 let-502(sb106) I 
RZB181 spv-1(ok1498) II; let-502(sb106) I  
WS4918 opIs310 [ced-1p::YFP::act-5::let-858 3'UTR + unc-119(+)] 
RZB180 
spv-1(ok1498) II; opIs310 [ced-1p::YFP::act-5::let-858 3'UTR + unc-
119(+)] 
RZB60 
spv-1(ok1498) II; msnEx60 [spv-1p::spv-1ΔF-BAR::GFP+pRF4(rol-
6(su1006))]  
RZB177 





OD70 ltIs44pAA173; [pie-1p-mCherry::PH(PLC1delta1) + unc-119(+)] 
NK358 unc-119(ed4) III; qyIs43[pat-3::GFP + ina-1(genomic) + unc-119(+)] 




2.2. Molecular cloning 
All cloning reactions were performed using the Q5 High Fidelity DNA Polymerase 
(NEB, Ipswich, MA).  Restriction enzymes, T4 DNA Ligase, T4 polynucleotide 
Kinase were purchased from NEB (Ipswich, MA). 2068 bp of the sequence directly 
upstream of the spv-1 start site and 3781 bp of the spv-1 genomic sequence were 
amplified from wild-type worm lysate. The remaining 3’ end of spv-1 was amplified 
using the Vidal ORF RNAi feeding clone as a cDNA template. The two fragments 
were combined with an intrinsic NdeI restriction site. The promoter-gene sequence 
was subsequently ligated into the pPD95.75 vector with a 3’ GFP sequence using PstI 
and XmaI restriction sites. spv-1 point mutation and deletion constructs were 
engineered by circle PCR cloning of the spv-1 full length plasmid. The SPV-1 
deadGAP was a substitution of an arginine residue to lysine at amino acid (AA) 635 
(performed by the Mechanobiology Protein Cloning and Expression Core Facility).   
SPV-1ΔRhoGAP was a deletion of AA 610 to 796 and SPV-1ΔF-BAR was a 
truncation of AA 195 to 405. The spermathea specific promoter of sth-1 was 
amplified from 2060 bp upstream of the sth-1 start codon and replaced the spv-1 
promoter with PstI and NheI restriction sites (NEB, Ipswich, MA). Generation of the 
sth-1 promoter-driven Rho-biosensor was done by cloning the AHPH anillin Rho-
binding domain from plasmid pKL26 (a kind gift from Michael Glotzer, U. Chicago, 
USA) (Tse et al., 2012). The PH domain was cloned from the worm lysis of OD70 
worm strain and inserted into the SPV-1ΔF-BAR construct to replace the F-BAR 
domain. The F-BAR region of SPV-1 (AA 192 – 462) was cloned into pEGFP-N1 
(Clontech, Mountain View, CA) between NheI and EcoRI restriction sites. RNAi 
feeding clones targeting Y37A1B.17 and Y105E8A.25 were amplified from worm lysis 
at full length gene transcript sequence positions 3449-7530 bp and 37957-41416 bp 
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respectively and ligated into the L4440 feeding vector at the NheI and XmaI 
restriction sites. All cloning reactions were verified for authenticity by sequencing. 
Plasmids and sequencing primers were submitted to 1st BASE Pte Ltd (Singapore) for 
sequencing reactions. Sequencing results were verified by performing an alignment 
with the expected sequence using Serial Cloner software. List of cloning primers used 




Table 2: List of cloning primers used in this study. 
spv-1 promoter + partial genomic 
sequence F 
AACTGCAGTGGTCTCATCTTCTGTCGGC 
spv-1 promoter + partial genomic 
sequence R 
CAAGTCCCGCATGGATTCTG 
spv-1 partial cDNA F TCGAACTGTAACTTCCAGAGC 
spv-1 partial cDNA R 
TCCCCCCGGGGAAGACGTGTCGATTCAACCT
TATC 
spv-1 ΔRhoGAP F TATCACATTTTTGGAATGGATCGAC 
spv-1 ΔRhoGAP R ATTTTGATGCTCTAAAAGTCCTTTC 
spv-1 ΔF-BAR F CAAACCCTGCCCACTCGAG 
spv-1 ΔF-BAR R ACTTCTACTCGGCGTATGATG 
sth-1 promoter F AACTGCAGCATTGGTAGTGTGAGCACCAC 
sth-1 promoter R 
CTAGCTAGCGTTGCTCTAGCACAAAAAGAC
TC 
spv-1 Δspv-1 promoter F 
CTAGCTAGCATGTCGTCGACGAGCAGTATAT
G 







PH F CACGGGCTCCAGGATGAC 




F-BAR R GGAATTCGCTCGTCAATTGAGCGATCCG 
Y37A1B.17 F CTAGCTAGCATGCTCTTACCAACTCGGCG 










2.3. Genotyping PCR 
Worms were lysed by incubating in lysis buffer (50 mM KCl, 10mM Tris pH8.2, 2.5 
mM MgCl2, 0.45% Tween-20,6 mg/ml Protease K) at 60 °C for 60 min. To confirm 
the identity of mutant worms, two PCR reactions were performed using 1) forward 
and reverse primers flanking the deletion site (Primers 1 and 2) and 2) forward primer 
in the deletion site paired with the reverse primer flanking the deletion site (Primers 2 









Table 3: List of genotyping primers used in this study. 
spv-1 (ok1498) F (flaking deletion site) AGGAGCTCTTCCAGACACCA 
spv-1 (ok1498) R (flaking deletion site) ATCGGTGTTGGCTCTACGTC 
spv-1 (ok1498) F (within deletion site) CAGAATGTTGTTCTGCACAAGC 
rhgf-1 (ok880) F (flaking deletion site) TGTAGGGATGCTATCTGGGG 
rhgf-1 (ok880) R (flanking deletion site) CGTAGTTTGCGCACTCACATC 




2.4. Generation of transgenic animals 
2.4.1. Genetic cross 
 
L4 hermaphrodites were incubated at 30° C for 5 h to induce the formation of male 
worms. Males were identified and confined with hermaphrodites of the desired strain 
(P0 generation) for 24 h to encourage mating. Successfully mated P0 hermaphrodites 
will give rise to heterozygous F1 progeny with a 50% male population. The F1 
progenies were isolated and allowed to propagate. F2 progenies homozygous for the 




Transgenic worms expressing the Rho-biosensor and various forms of the SPV-1 
constructs were generated by injection. The injection mix contained 100 ng/μl 
pBluescript as carrier DNA, 20 ng/μl rol-6 (su1006) co-injection marker and 10 ng/μl 
of plasmid carrying the construct of interest. Worms were mounted on desiccated 3% 
agarose pads coated with mineral oil (Sigma-Aldrich, St. Louis, MO). The injection 
needle was prepared from a glass capillary (Narishige, Japan) using a P-97 
Flaming/Brown Micropipette Puller (Sutter Instruments, Novato, CA). The 
microscope setup is as follow: Nikon Ti microscope (Nikon, Tokyo, Japan), S Plan 
Fluor 40x objective (Nikon, Tokyo, Japan), Eppendorf PatchMan NP2 
micromanipulator (Eppendorf, Hamburg, Germany). The mixture was injected into 
the gonad of young adult hermaphrodites using a nitrogen gas-powered pump on the 
injector. Injected worms were transferred onto NGM plates with a drop of M9 buffer 
(2.2 mM KH2PO4, 4.2 mM Na2HPO4, 85.6 mM NaCl, 1 mM MgSO4) to aid worm 
recovery. The progenies of the injected worms (F1 generation) showing a roller 
phenotype were isolated onto individual plates. Each P1 worm that successfully 
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2.5. Progeny test 
Adult worms were placed for several hours on NGM plates seeded with OP50 
bacteria to allow them to lay embryos. Next, the adult worms were removed and the 
number of embryos on the plates was counted. The embryos were incubated for 24 h 
at 20 C, after which the number of hatched progenies was scored. Embryonic 
lethality was calculated from the following formula: 
 
                                                   
                       




2.6. RNAi knockdown by feeding 
RNA interference (RNAi) feeding clones were mostly from Vidal (OpenBioSystems) 
and Ahringer (Source BioScience) libraries (Table 4). RNAi clones for rhgf-1, rhgf-2, 
pix-1 and unc-73 were kindly provided by Erin Cram (Northeastern University, 
Boston, MA), par-5 was a kind gift from Takao Inoue (National University of 
Singapore). Clones targeting Y37A1B.17 and Y105E8A.25 were generated in-house 
(refer to Section 2.2). To induce the transcription of dsRNA in the feeding clones, 
bacteria was plated on isopropyl β-D-1-thiogalactopyranoside (IPTG) plates, which 
were prepared by supplementing NGM agar plates with 50 µg/ml Carbenicillin and 1 
mM IPTG. RNAi feeding bacteria was inoculated in LB broth supplemented with 100 
µg/ml Ampicillin. 50-200 µl of the overnight bacteria culture was seeded onto the 
IPTG plates and incubated overnight at room temperature. Worm strains of interest 
were transferred onto IPTG plates seeded with bacteria and incubated at either 20 or 
25° C for 24-72 h. Bacteria carrying the L4440 empty vector were used as a negative 
control whereas par-5 and rho-1 targeting clones were positive controls for 
experiments involving embryonic lethality and spermathecal contractility 




Table 4: List of RNAi clones from the Vidal and Ahringer libraries. 








  rrc-1 
  tag-341 
  tag-52 
  Y95B8A.12 
  vav-1 




2.7. In vitro RhoGAP activity assay 
A bacterially produced protein containing the C terminus of SPV-1 (AA 584 – 966) 
inclusive of the RhoGAP domain was prepared by the Protein Production Platform 
(Nanyang Technological University, Singapore). Briefly, The RhoGAP domain, 
positions 1750 – 2898 bp of spv-1 cDNA, was cloned into the pNIC28-Bsa4 vector 
harboring the His-TEV tag and transformed into BL21 for protein expression. Protein 
was purified using Ni-NTA column followed by gel filtration chromatography. 
RhoGAP activity of the recombinant SPV-1 fragment was evaluated with the in vitro 
RhoGAP assay (Cytokskeleton) according to manufacturer’s protocol. Briefly, the 
GAP protein was incubated with RhoA and excess GTP for 20 min at 37 °C. The 
catalytic domain of p50 RhoGAP was used as a positive control.  Release of inorganic 
phosphate (Pi) was visualized by the addition of CytoPhos reagent and measured at 





Protein domains for SPV-1 were identified by conducting a conserved domain search 
(Marchler-Bauer et al., 2011). Paircoil2 was utilized to predict the presence of coiled-
coil regions (McDonnell et al., 2006). Structure predictions for full-length and the F-
BAR domain of SPV-1 were performed using Phyre2 (Kelley and Sternberg, 2009) 
and I-TASSER (Roy et al., 2010) respectively. DELTA-BLAST was used to identify 
orthologs of SPV-1 (Boratyn et al., 2012). Multiple sequence alignment of the F-BAR 
region across the metazoan phylum was performed with T-coffee (Notredame et al., 
2000) and visualized with Jalview (Waterhouse et al., 2009). Phylogenetic analysis of 
the F-BAR sequences was performed with PHYLIP-NEIGHBOR (MPI 
Bioinformatics Toolkit) (Biegert et al., 2006) and an unrooted phylogenetic tree was 




2.9. Cell culture 
HeLa cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) 
(Invitrogen) supplemented with 10% Fetal Bovine Serum (FBS) (Invitrogen) and 1% 
Penicilin-Streptomycin (Invitrogen) and incubated in 37° C at 5% CO2 atmosphere. 
Cells for imaging were seeded on 30 mm glass coverslip and transfected with 1 μg of 
F-BAR::GFP plasmid using Lipofectamine 2000 (Invitrogen) in accordance to the 
manufacturer’s instructions. Cells were imaged 24 h post transfection in DMEM.  
Cell membrane was stained with a membrane dye DiI 561by incubating cells in 
1:1000 dilution of dye:PBS for 5min, followed by three 5 min wash in PBS. 
Trypsinization was performed by removing the DMEM and replacing with Trypsin 
(Invitrogen). The trypsin reaction was quenched with excess DMEM.  
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2.10. Image acquisition 
2.10.1. Microscope setup 
 
Images in Figures 5A, 7B, 8, 10A, 11B, 12A, 13D, 14A, 23 DIC panel, 24, 25 and 29 
were acquired with a Nikon Ti microscope (Nikon, Tokyo, Japan) mounted with a 
differential interference contrast (DIC) 1.40NA oil condenser (Nikon, Tokyo, Japan) 
and a charged-coupled device (CCD) camera (CoolSNAP HQ2, Photometrics, 
Tucson, AZ), using either 20x S Plan Fluor 0.45NA air objective or 60x Plan-Apo 
1.40NA oil objective (Nikon, Tokyo, Japan). The remaining images were captured on 
a spinning disk confocal microscope composed of Nikon Ti microscope base (Nikon, 
Tokyo, Japan) with CSU-X1 spinning-disk confocal head (Yokogawa Corporation, 
Tokyo, Japan), DPSS-Laser (Roper Scientific, France) at 491nm excitation 
wavelength, and an Evolve Rapid-Cal electron multiplying charged-coupled device 
(EMCCD) camera (Photometrics, Tucson, AZ) using either 60x or 100x Plan-Apo 
1.40NA oil objectives (Nikon, Tokyo, Japan). Metamorph software (Molecular 
Devices, Sunnyvale, CA) was used to control the acquisition. All imaging was 
performed at 20 °C. 
 
2.10.2. Preparation of sample slides 
 
For preparation of embryo mounts, gravid hermaphrodites were dissected in M9 
buffer to release the embryos. Embryos were transferred onto a 3% agarose pad on a 
glass slide. To image embryo transit, a single adult hermaphrodite was placed on 10% 
agarose with a drop of M9 buffer. A glass coverslip was placed on top of the sample 
and the space between the coverslip and slide was infused with M9 buffer. The edges 




2.10.3. Image analysis and quantification 
 
Images and movies were analyzed using ImageJ (NIH). Quantification of the 
constriction magnitude was performed by calculating the ratio of the measured width 
between distal and proximal ends of the spermatheca during embryo transit. Valve-to-
valve time was the quantification of time elapsed between the closure of the distal 
valve and opening of the sp-ut valve. Measurement of embryo cross-section area was 
done by manually tracing the perimeter of the embryos imaged at a medial plane. 
Quantification of the embryo axial ratio was obtained by the ratio between 
measurements of the long over the short axis. Intensity changes of the Rho-biosensor 
in the spermatheca were measured by quantifying the mean intensity of the whole 
spermatheca at the middle focal plane across time and normalized to the intensity at 
the first time point. Membrane and cytoplasm intensities for SPV-1 localization were 
obtained by manually tracing along the cell edge or cytoplasm. Membrane-to-
cytoplasm ratio of SPV-1 localization was the ratio between the mean intensities for 
the line traces at the cell edge and cytoplasm. Data sets were statistically analysed 
(two-tailed unpaired t test for Figures 10B,C, 11A and 15B; ordinary one-way 
















3.1. RHO-1 is a key regulator of spermathecal contractility 
The spermatheca undergoes periodic constriction and relaxation during embryo transit 
events. The presence of NMY-1/non-muscle myosin II (Kovacevic et al., 2013) and 
circumferential actin bundles visualized by YFP::ACT-5 (Figure 7A) as well as 
phalloidin staining (Kovacevic and Cram, 2010) in the spermathecal cells suggest the 
actomyosin machinery is the driving force of spermatheca contractililty. Furthermore, 
the well-established antagonistic functions of LET-502/Rho-kinase and MEL-
11/Myosin light chain phosphatase in maintaining the balance between constriction 
and relaxation in the spermatheca (Wissmann et al., 1999), suggests the involvement 
of RHO-1 as an upstream regulator in the temporal regulation of spermathecal 
constriction. However, since the contribution of RHO-1 in spermathecal contractility 
has not been reported, we directly tested the involvement of RHO-1 during embryo 
transit by performing a partial knockdown of RHO-1 by RNAi feeding. In a mock 
RNAi knockdown in the wild type background, the representative images showed the 
oocyte fully entered into the spermatheca (indicated as time = 0) and resided in the 
spermatheca for 213 sec (mean ± SEM = 244.3 ± 11.8, n = 12) (Figure 7B). This was 
followed by the opening of the sp-ut valve and initiation of embryo exit. The newly 
fertilized embryo completed its exit from the spermatheca after 345 sec.  A 36 h 
knockdown of RHO-1 resulted in complete loss of spermathecal constriction leading 
to multiple embryos trapped in the spermatheca (Figure 7B, n = 14). The embryos 
failed to exit the spermatheca in the 30 min imaging timeframe. Retaining of embryos 
in the spermatheca during loss of RHO-1 phenocopies the loss of NMY-1 and LET-
502 (Kovacevic et al., 2013; Wissmann et al., 1999).  Loss of RHO-1 likely hindered 
the activation of downstream LET-502 and phosphorylation of NYM-1, hence 
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Figure 7: RHO-1 is essential for spermathecal constriction.   
(A) Circumferential actin bundles in the wild-type spermatheca visualized by 
YFP::ACT-5. Scale bar = 20 μm. 
(B) Effects of RHO-1 knockdown in the wild-type spermatheca. Representative 
images of an embryo transit event taken from L4440 (negative control) and rho-1 
(RNAi) treated worms. In rho-1 knockdown, embryos (highlighted in pink) remain in 
the spermatheca (highlighted in orange) throughout the 30 min imaging period. n ≥ 
12, Oo: oocyte, Sp: spermatheca. Scale bar = 20 μm. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2. Identification and characterization of a RhoGAP involved in 
spermathecal constriction 
 
3.2.1. Loss of SPV-1 results in spermathecal overconstriction 
 
To identify upstream regulators of RHO-1 activity in the spermatheca, we performed 
a candidate screen of RhoGAPs in the C. elegans genome by RNAi feeding. The 
RhoGAP candidates tested are listed in Table 5. We reasoned that if spermathecal 
functions were perturbed, the resulted embryos would take on an irregular appearance 
as well. For all the candidates screened, temporary assigned gene (tag)-341 was the 
only gene that gave embryos of abnormal morphology when knocked down by RNAi 
feeding at 25 °C for 48 h (Figure 8). The arrows indicate elongated embryos while the 
arrowhead points to a round embryo. We have since renamed tag-341 to spermatheca 
physiology variant (spv)-1.  
 
To further characterize the contribution of spv-1 in spermathecal constriction, a 
deletion allele, spv-1 (ok1498), was obtained from the CGC.  The spv-1 gene consists 
of 18 exons and 17 introns (Figure 9A). The 577 bp frame shift deletion mutant spv-1 
(ok1498) lacks part of the RhoGAP sequence. Genotyping was performed by using a 
combination of two primers flanking the deletion site (Figure 9A, inset, primers 1 and 
3) and one internal with one external primer (Figure 9A, inset, primers 2 and 3) to 
confirm the identity of the mutant worms. Using primers flanking the deletion region 
(primers 1 and 3), PCR amplification of the wild type worm gave a 2991 bp band 
whereas a 577 bp deletion in the mutant allele resulted in a lower molecular weight 
2414 bp band (Figure 9B, left panel). Amplification using primers 2 and 3 resulted in 
a 2327 bp band for the wild-type allele and the absence of a band confirms the 
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absence of a wild-type allele in the mutant (Figure 9B, right panel). These results 
confirmed the identity of the spv-1 (ok1498) deletion allele. Since the mutation was 
generated by UV/TMP irradiation, we outcrossed the mutant allele twice with wild-
type males to remove background mutations. The twice-outcrossed spv-1 (ok1498) 
allele was used for further characterization.   
 
We analyzed embryo transit events in wild-type and spv-1 (ok1498) mutants using 
differential interference contrast (DIC) microscopy (Figure 10A). Complete 
ovulation, defined by the complete closure of the distal valve upon oocyte entry into 
the spermatheca, is referred to as time 0. The embryo residence time in the 
spermatheca termed ‘valve-to-valve’ time is defined as the time elapsed between 
closure of the distal valve and opening of the sp-ut valve. In wild-type worms, 
embryos resided in the spermatheca for 247.2 (mean) ± 11.61 (SEM) sec before the 
spermatheca constricted and propelled the embryo into the uterus (n = 23) (Figure 
10A,B). This was significantly different (p<0.0001) from the 94.50 ± 10.29 sec of 
valve-to-valve time for spv-1 (ok1498) (n = 28) (Figure 10A, B). To quantitatively 
assess the magnitude of spermatheal constriction, we measured the width at its distal 
(W1) and proximal (W2) quarters prior to initiation of embryo exit and calculated the 
W1/ W2 ratio. spv-1 (ok1498) (n = 28) showed a 31% increase in constriction 
magnitude compared to wild-type spermatheca (n = 23) during embryo transit (Figure 
10B). To further validate that the difference in constriction magnitude was 
contributed by a stronger distal constriction in spv-1 (ok1498) mutant, we plotted the 
individual spermatheca width for both distal and proximal ends  (Figure 10C). As 
expected, the proximal width (W2) did not differ significantly between wild-type 
(23.96 ± 0.6) and mutant (23.55 ± 0.5) worms whereas the distal width was 
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significantly reduced in the mutant.(p<0.0001) (Figure 10C).Taken together, 
quantifications of valve-to-valve time and constriction magnitude suggested that 
premature exit of the embryo in the spv-1 (ok1498) mutants resulted from the 
precocious and excessive constriction of the spermathecal cells. Hence, we followed 
the changes in constriction magnitude over the course of a single embryo transit event 
in both wild-type and mutant worms (Figure 10D). The wild-type spermatheca 
showed slightly elevated W1/ W2 ratio during the initial phase of embryo transit that 
gradually plateaued and decreased slightly prior to sp-ut valve opening (n = 7). On the 
contrary, the width of the spermatheca for spv-1 (ok1498) mutants decreased 
immediately upon completion of ovulation and continued to decrease until initiation 
of embryo exit (n =7). This further corroborated the finding that loss of spv-1 resulted 
in premature and excessive spermathecal constriction. 
 
An increase in constriction magnitude could be expected to lead to accelerated 
embryo exit time, defined by the time from initiation of embryo exit from the 
spermatheca to completion of exit into the uterus. However, the mean embryo exit 
time between wild-type (92.35 ± 12.84, n = 23) and spv-1 (ok1498) mutant (115.8 ± 
13.84, n = 24) was not significantly different (Figure 11A). We attributed this to the 
spermatheca behaving like a vice during constriction in the spv-1(ok1409) mutants 
and preventing embryo exiting the spermatheca and sometimes completely severing 

















Figure 8: Loss of SPV-1 results in embryos of irregular geometry. 
Wild type worms treated with mock RNAi shows stereotypical embryo shape (left 
panel). Embryos from spv-1 RNAi treated worms have aberrant morphology (right 
panel). Arrows indicate elongated embryos while arrowhead points to a round 
embryo. Scale bar = 20 μm.  
 





Figure 9: Genotyping of the spv-1 (ok1498) mutant allele. 
(A) Gene structure of the spv-1 locus. Rectangles and lines represent exons and 
introns respectively. DNA sequence coding for the RhoGAP domain is marked in red. 
The deletion region in spv-1 (ok1498) is indicated by a bracket. Inset shows the 
location of genotyping primers.   
(B) Gel image of spv-1 (ok1498) genotyping. External primers (1 and 3) gives a 2991 
bp and 2414 bp band for wild-type and spv-1 (ok1498) mutant respectively. The 
internal and external primer paring (2 and 3) resulted in a 2327 bp band for wild-type 






Figure 10: SPV-1 is a negative regulator of spermathecal contractility. 
(A) Representative images of embryo transit events in wild-type and spv-1 (ok1498) 
mutants. Complete ovulation is defined by the closure of the distal valve following 
ovulation. Initiation of embryo exit is defined by the opening of the sp-ut valve. 
Valve-to-valve time represents the elapsed time between complete ovulation and 
initiation of embryo exit. W1 and W2 represent the width of the spermatheca at the 
first and last quarter respectively.  Oo: oocyte, Sp: spermatheca. Scale bar = 20 μm.   
(B) Quantifications of valve-to-valve time and constriction magnitude in wild-type 
and spv-1 (ok1498) mutant animals. Each data point (grey dot) is a single embryo 
transit event. Data are represented by mean ± SEM with n ≥ 23 for each worm strain 
analyzed. Statistical comparisons were performed using two-tailed unpaired t test.   
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(C) Quantifications of spermatheca width at the distal (W1) and proximal (W2) ends 
of wild-type and spv-1 (ok1498) mutant animals. Data are represented by mean ± 
SEM with n ≥ 23 for each worm strain analyzed. Statistical comparisons were 
performed using two-tailed unpaired t test. Data points were used to quantify the 
constriction magnitude in (B).  
(D) Quantification of the dynamic changes in spermatheca constriction magnitude 
during embryo transit in wild-type and spv-1(ok1498) mutants. Measurements were 
taken at 30 sec intervals from closure of the distal valve to opening of the sp-ut valve. 
Each line represents one embryo transit event. N = 7 for each strain. 
 






Figure 11: Defective embryo exit in spv-1 (ok1498) animals. 
(A) Quantification of embryo exit time (the time taken from opening of the sp-ut 
valve till complete exit of the embryo from the spermatheca) in wild-type and spv-
1(ok1498) worms. Each data point (grey dot) is a single embryo transit event. Data 
are represented by mean ± SEM with n ≥ 23 for each worm strain analyzed. Statistical 
comparisons were performed using two-tailed unpaired t test.   
(B) Representative images of hyperconstricted spermatheca in spv-1(ok1498) worms 
demonstrating how an embryo can be trapped like in a vise (left) and severed (right). 
Scale bar: 20 μm 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.2. Loss of spv-1 results in misshapened embryos and increases lethality 
 
As a consequence of the excessive constriction in spv-1 loss-of-function worms, we 
observed deformation and pinching of the embryos during the ovulation process 
(Figure 11B). This resulted in the formation of embryos of aberrant morphology 
(Figure 8, Figure 12A). The stereotypical geometry of wild-type embryos is an 
ellipsoid with mean axial ratio and area of 1.69 and 1372 μm2 respectively (n = 50) 
(Figure 12B). On the contrary, spv-1 (ok1498) and knockdown of spv-1 by RNAi 
resulted in a large distribution of axial ratio and area size ranging from 1.00 – 2.38 
and 379.4 – 1866.8 μm2 respectively (n > 50) (Figure 12B). In addition, loss of spv-1 
also resulted in embryonic lethality of 41% and 50% for spv-1 (ok1498) and spv-1 
(RNAi) respectively (Figure 12C). Interestingly, we observed a bias for developmental 
arrest for embryos that fall below a critical axial ratio of 1.69 (Figure 12B). Although 
most of the small embryos probably failed to hatch due to lost of cytoplasmic content, 
rounder than normal embryos that fell within the wild-type range of area (yellow 
band) showed a higher percentage of lethality that was not observed for embryos that 
were abnormally elongated. This hinted at the possibility that embryonic lethality 






Figure 12: SPV-1 contributes to formation of stereotypical embryo shape and 
embryonic viability. 
(A) Wild-type and spv-1 (ok1498) mutant embryos. Arrows and arrowheads indicate 
elongated and round embryos respectively.  Scale bar = 50 μm.   
(B) Comparison of the area and axial ratio distribution between wild-type, spv-
1(ok1498) mutant and spv-1 knock-down embryos. Dotted lines represent the mean 
values for the x- and y-axis for the wild-type embryos, and the region highlighted in 
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yellow marks the wild-type range of embryo area. Each dot represents a single 
embryo with blue and grey dots indicating embryos that arrested and hatched 
respectively. N ≥ 50 for each strain quantified.   
(C) Quantification of embryonic lethality in wild-type, spv-1 (ok1498) and spv-1 
(RNAi) treated worms. N represents the number of embryos scored. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.3. SPV-1 is expressed exclusively in the spermatheca 
 
Given the apparent function of SPV-1 in the spermatheca, we next proceeded to 
determine its expression pattern. We engineered a translational fusion construct of 
SPV-1::GFP driven by the spv-1 endogenous promoter. SPV-1::GFP was observed 
exclusively in the spermatheca (Figure 13A, arrowhead). It is worth noting that the 
prominent fluorescence in the worm intestine is a result of gut granule 
autofluorescence (Figure 13A, arrow). Importantly, expression of the SPV-1::GFP 
fusion protein in the spv-1 (ok1498) background successfully rescued all the mutant 
phenotypes: constriction magnitude and valve-to-valve time was restored to wild-type 
levels (n = 23) (Figure 13B), embryonic lethality was eliminated (n = 370) (Figure 
13C), and embryo geometry was restored to wild-type dimensions (Figure 13D). 
Thus, we concluded that the fusion protein is functional. SPV-1 expression observed 
in the spermatheca was consistent with the overconstriction phenotypic in worms 
lacking spv-1. Importantly, we did not detect SPV-1 expression in the embryos 





Figure 13: SPV-1 is exclusively expressed in the spermatheca. 
(A) SPV-1::GFP under the regulation of its endogenous promoter is expressed in the 
spermatheca (arrowheads). Arrows indicate autofluorescence of the gut granules. 
Asterisk denotes the embryos. Scale bar = 100 μm.  
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(B) Quantification of the constriction magnitude and valve-to-valve time in SPV-
1::GFP transgenic line. Data from wild-type and spv-1 (ok1498) were duplicated from 
Figure 9. Each data point (grey dot) is a single embryo transit event. Data are 
represented by mean ± SEM with n ≥ 23 for each worm strain analyzed. Statistical 
comparisons were performed using one-way ANOVA-Tukey’s multiple comparisons 
test.   
(C) Quantification of embryonic lethality in wild-type, spv-1 (ok1498) and spv-
1p::spv-1::GFP  worms. Data from wild-type and spv-1 (ok1498) were duplicated 
from Figure 11. N represents the number of embryos scored.   
(D) DIC image of spv-1p::spv-1::GFP embryos. Scale bar = 20 μm. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.4. SPV-1 function in the spermatheca is essential for embryogenesis 
 
The observation of a bias in developmental arrest in round embryos (Figure 12B) 
combined with the lack of embryonic expression for SPV-1 (Figure 13A) suggested 
that the embryonic lethality associated with loss of spv-1 function is solely 
contributed by the aberrant embryo morphology as a consequence of spermathecal 
overconstriction. To further validate that SPV-1 is not essential for embryogenesis, 
we drove SPV-1::GFP expression with the spermatheca specific promoter sth-1 
(Bando et al., 2005). The spermathecal specific expression of SPV-1::GFP was able to 
successfully rescue embryonic lethaility (Figure 14A) along with embryo shape defect 
(Figure 14B). Furthermore, we performed a genetic cross between spv-1 (ok1498) 
hermaphrodites with either wild-type or spv1 (ok1498) males and scored for 
embryonic lethality. If spv-1 gene function within embryos is essential for embryonic 
development, the introduction of a wild-type copy of the spv-1 locus to the spv-1 
(ok1498) mutant should rescue the embryonic lethality of F1 heterozygous progenies 
but will not alleviate spermathecal overconstriction in the parent spv-1 (ok1498) 
hermaphrodite. Interestingly, we observed a slight reduction in embryonic lethality in 
cross-progeny regardless of the phenotype of the males (Figure 14C), probably due to 
the presence of an unknown relaxing effect of the male sperm on the spermatheca. 
Taken together, our results suggest that SPV-1 function within the spermatheca, but 
not within the embryo, is essential for embryogenesis. We hypothesize that embryonic 
lethality observed with loss of SPV-1 could be due to the irregular embryo shape as a 






Figure 14: SPV-1 is not essential for embryo development. 
(A) Quantification of embryonic lethality in wild-type, spv-1 (ok1498) and sth-
1p::spv-1::GFP  worms. Data from wild-type and spv-1 (ok1498) were duplicated 
from Figure 11. N represents the number of embryos scored.   
(B) DIC image of sth-1p::spv-1::GFP embryos. Scale bar = 20 μm.   
(C) Results of 3 independent mating experiments, in which embryonic lethality was 
quantified for self progeny and cross progeny of spv-1(ok1498) hermaphrodites mated 
with either wild-type males or spv-1(ok1498) males. Cross progeny was identified by 
the presence of males in the F1 generation. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.5. The RhoGAP domain of SPV-1 functions upstream of RHO-1/LET-
502 signaling pathway 
 
Since SPV-1 is a RhoGAP domain-containing protein, we hypothesized that it is 
regulating spermatheca contractility upstream of RHO-1/RhoA. To test this, we 
performed a rho-1 knockdown by RNAi feeding in the background of spv1- (ok1498) 
mutant and tested for a phenotypic rescue in spermathecal constriction. As expected, 
the 24 h rho-1 RNAi treatment successfully restored normal embryo transit (Figure 
15A,B), suggesting that the hypercontractile phenotype in spv-1 loss-of-function was 
due to excessive RHO-1 activity. To monitor RHO-1 levels in the spermatheca during 
embryo transit, we utilized a rho-biosensor harboring the rho-binding domain of C. 
elegans anillin (AHPH::GFP) (Tse et al., 2012) and drove its expression in the 
spermatheca with the sth-1 promoter. The rho-binding domain of anillin selectively 
binds the GTP-bound form of active RHO-1, resulting in an accumulation of 
AHPH::GFP at the site where active RHO-1 is present, hence an increase in 
fluorescence intensity. In wild-type animals, we observed a gradual increase in the 
intensity of the RHO-1 sensor at the distal end of the spermatheca after completion of 
oocyte entry, and the intensity peaked during embryo exit (Figure 16A,B, arrows). In 
contrast, the spermatheca in spv-1 (ok1498) worms displayed a sharp increase in the 
intensity of the Rho-biosensor at the distal end of the spermatheca immediately upon 
completion of oocyte entry (Figure 16A,B, arrowheads). We confirmed the efficacy 
of the Rho-sensor by reducing RHO-1 in spv-1 (ok1498) through RNAi feeding. 
Under these conditions, the premature accumulation of the rho-biosensor in the spv-1 
(ok1498) spermatheca was abolished (Figure 16C,D). Based on these results we 
concluded that in the absence of spv-1 higher levels of activated RHO-1 lead to 




We postulated that the RhoGAP domain of SPV-1 is a direct upstream negative 
regulator of RHO-1 activity. To test this, we performed an in vitro RhoGAP activity 
assay using purified proteins. Incubating recombinant mammalian RhoA protein with 
the RhoGAP domain of SPV-1 in the presence of GTP showed a significant increase 
in phosphate released (p<0.001) as compared to the intrinsic hydrolysis of RhoA with 
GTP alone (Figure 17A). To establish that the RhoGAP domain is functionally 
essential in vivo, we engineered a construct with a nonfunctional RhoGAP domain, 
SPV-1(R635K)::GFP, by introducing a point mutation at the RHO-1 catalytic site. As 
expected, the deadGAP construct failed to rescue the overconstriction phenotype of 
spv-1 (ok1498) in terms of constriction magnitude and valve-to-valve time (Figure 
17B). We obtained similar results with a complete deletion of the RhoGAP domain 
(Figure 17B). These findings corroborate our hypothesis that the RhoGAP domain of 
SPV-1 functions to suppress RHO-1 activity in the spermatheca.  
 
It is well established that RhoA regulates contractility via two distinct pathways: 1) by 
promoting actin polymerization through activation of diaphanous formins (Watanabe 
et al., 1999) and 2) activation of Rho-kinase and subsequence phosphorylation of 
myosin light chain (Amano et al., 1996; Kimura et al., 1996). To test if the first 
mechanism was at play in the spermatheca, we utilized YFP::ACT-5 as an actin 
marker to visualize actin organization in the spermatheca. There were no discernable 
differences between circumferential actin bundles in wild-type and spv-1 (ok1498) 
mutant worms at the resolution of the light microscope (Figure 18A). To determine 
the contribution of LET-502/Rho kinase in RHO-1-dependent spermathecal 
constriction, we performed a genetic cross between spv-1 (ok1498) and the let-502 
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(sb106) hypomorphic mutant. The spv-1(ok1498);let-502(sb106) double mutant 
restored the constriction magnitude to a similar ratio to the let-502 (sb106) single 
mutant alone (Figure 18B). This is in line with the hypothesis that SPV-1 negatively 
regulates contractility upstream of RHO-1/LET-502. However, the slight increase in 
valve-to-valve time for the spv-1 (ok1498);let-502 (sb106) double mutant was not 
significantly different from spv-1 (ok1498) mutant alone (Figure 18B). One plausible 
explanation for the incomplete rescue could be that the hypomorphic properties of let-






Figure 15: Reduced RHO-1 activity alleviates the spv-1(ok1498) mutant 
phenotype. 
(A) Representative images of embryo transit events in spv-1 (ok1498) mutants treated 
with control (L4440) or rho-1 (RNAi). Complete ovulation is referred to as time 0 sec. 
The precocious and hyperconstricted phenotype of the mutant spermatheca is reverted 
to wild-type phenotype under rho-1(RNAi) condition. Oo: oocyte, Sp: spermatheca. 
Scale bar = 20 μm.   
(B)  Quantifications of valve-to-valve time and constriction magnitude spv-1 (ok1498) 
mutant animals treated with control (L4440) or rho-1 (RNAi).  Each data point (grey 
dot) is a single embryo transit event.  Data are represented by mean ± SEM with n ≥ 5 
for each worm strain analyzed.  Statistical comparisons were performed using two-
tailed unpaired t test.   
 








































































































Figure 16: RHO-1 activity is elevated in spv-1 (ok1498) mutant. 
(A) Representative images of wild-type and spv-1 (ok1498) mutant worms carrying 
the active RHO-1 biosensor (AHPH::GFP). Arrows and arrowheads indicate an 
accumulation of AHPH::GFP. Scale bar = 20 μm.   
(B) Line plots of mean fluorescence intensity measured at 10 sec intervals for the 
ovulation process shown in (A). Arrows mark the point when embryo exit begins. The 
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end of the line corresponds with the final image at 300 sec and 180 sec for wild-type 
and spv-1 (ok1498) mutant respectively. 
(C) Live imaging of active RHO-1 biosensor (AHPH::GFP) in spv-1(ok1498)  
spermatheca in control (L4440) and rho-1(RNAi) conditions to demonstrate the 
efficacy of the Rho-biosensor. Arrows and arrowheads indicate an accumulation of 
AHPH::GFP. Scale bar = 20 μm. 
(D) (B) Line plots of mean fluorescence intensity measured at 10 sec intervals for the 
ovulation process shown in (C). Arrows mark the point when embryo exit begins. The 
end of the line corresponds with the final image at 160 sec and 240 sec for control and 





Figure 17: The RhoGAP domain of SPV-1 negatively regulates RHO-1 activity. 
(A) In vitro RhoGAP activity assay measuring GAP activity toward recombinant 
mammalian RhoA shows GAP activity of the RhoGAP domain of SPV-1. The 
catalytic domain of human p50 GAP was used as a positive control.  
(B) Quantification of the constriction magnitude and valve-to-valve time in spv-1 
(ok1498) and transgenic worms depleted of RhoGAP activity. Data from spv-1 
(ok1498) is duplicated from Figure 9. Each data point (grey dot) is a single embryo 
transit event. Data are represented by mean ± SEM with n ≥ 23 for each worm strain 
analyzed. Statistical comparisons were performed using one-way ANOVA-Tukey’s 
multiple comparisons test.  
 




Figure 18: LET-501/Rho-kinase functions downstream of SPV-1. 
(A) Circumferential actin bundles in wild-type and spv-1 (ok1498) visualized with 
YFP::ACT-5. Image from the wild-type panel is duplicated from Figure 6.  
(B) Quantification of the constriction magnitude and valve-to-valve time in spv-1 
(ok1498) and let-502 (sb106) single and double mutants. Data from spv-1 (ok1498) is 
duplicated from Figure 9. Each data point (grey dot) is a single embryo transit event. 
Data are represented by mean ± SEM with n ≥ 23 for each worm strain analyzed. 
Statistical comparisons were performed using one-way ANOVA-Tukey’s multiple 
comparisons test.  
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.6. SPV-1 localizes transiently to the plasma membrane 
 
To investigate the intracellular localization of SPV-1 during an embryo transit event, 
we performed time-lapse imaging of SPV-1::GFP transgenic worms using confocal 
microscopy (Figure 19A). During the initial phase of embryo transit (Figure 19A, 
time 0 sec), an intense accumulation of SPV-1::GFP was observed at the apical 
membrane. A line profile taken across the width of a single spermatheca cell at 0 sec 
gave a distinct peak (Figure 19A, black triangle) representing enrichment of SPV-
1::GFP at the membrane compared to the intensity at the cytoplasm (Figure 17A, 
open triangle). Interestingly, membrane accumulation of SPV-1::GFP was gradually 
diminished and disappeared (180 sec) prior to opening of the sp-ut valve (360 sec) 
(Figure 19A).  We attributed the gradual detachment of SPV-1 from the membrane to 
the flattening of nanoscopic membrane folds in the apical membrane of spermathecal 
cells. 
 
To correlate the spatiotemporal changes of SPV-1 membrane localization with RHO-
1 activity, we quantified the membrane-to-cytoplasm ratio of SPV-1 alongside 
quantification of RHO-1 levels from completion of ovulation to the end of embryo 
transit (Figure 19B). We observed a gradual reduction in membrane localization of 
SPV-1::GFP during the course of embryo transit and membrane signal was 
completely lost halfway through the embryo retention period. At the same time, total 
Rho-biosensor intensity displayed the opposite trend with lower levels in the initial 
stage of embryo transit that reached maximum intensity just prior to completion of 
embryo exit. The complementary trend of SPV-1 localization and RHO-1 activation 
led us to speculate that membrane-localized SPV-1 functions to suppress RHO-1 
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activity. Gradual detachment of SPV-1 from the membrane during embryo transit 





Figure 19: SPV-1 is transiently localized to the apical plasma membrane. 
(A) Representative images of SPV-1::GFP driven by the spv-1 promoter showing its 
subcellular localization during embryo transit. Graphs show the intensity profile of 
lines drawn perpendicular to the spermatheca cells. Black arrowhead indicates the 
peak intensity corresponding to the apical membrane. Open arrowhead represent the 
baseline intensity in the cytoplasm. Scale bar: whole spermatheca – 20 μm; inset – 5 
μm.   
(B) Quantification of SPV-1::GFP membrane accumulation and AHPH::GFP total 
intensity during embryo transit. The valve-to-valve time (time interval between 
completion of ovulation and initiation of embryo exit) on the x axis is normalized to a 
scale of 0–1 to enable the line plots to be superimposed on the same graph. Light-
colored lines represent individual embryo transit events; bold lines are mean values 
quantified from the light-colored lines.  
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.7. SPV-1 contains a novel F-BAR domain 
 
Next, we sought to understand how transient SPV-1 localization is regulated. To this 
end we first performed a bioinformatics analysis on the SPV-1 amino acid sequence 
to elucidate the protein domain architecture. A conserved domain search (Marchler-
Bauer et al., 2011) revealed that in addition to the RhoGAP domain, SPV-1 also 
contains an N terminus Fes/Cip4 homology (FCH) domain and a 
phorbolesters/diacylglycerol binding (C1) domain (Figure 20A, top panel). A coiled-
coil motif prediction software (McDonnell et al., 2006) predicted (with probability 
score > 0.5) the presence of a coiled-coil (CC) region closely succeeding the FCH 
domain (Figure 20A, top panel). Based on previous studies, an FCH followed by a 
coiled-coil domain could indicate the presence of an F-BAR domain (Itoh et al., 2005; 
Tsujita et al., 2006). Figure 20B, bottom panel shows the predicted protein structure 
of full-length SPV-1 modeled using Phyre2 with 78% of residues modeled at >90% 
confidence (Kelley and Sternberg, 2009).  
 
To investigate the conservation of the putative F-BAR domain across species, we first 
identified orthologs of SPV-1 from sponges to mammals using the Domain Enhanced 
Lookup Time Accelerated Basic Local Alignment Search Tool (DELTA-BLAST) 
(Boratyn et al., 2012). Noteworthy, vertabrates have three SPV-1 orthologs while 
metazoan species up to chordates only have a single ortholog. The three SPV-1 
human orthologs are: Rho GTPase-activating protein 29 (ARHGAP 29/PARG1), 
GEM interacting protein (GMIP) and human minor histocompatibility antigen 1 
(HMHA1). It is noteworthy that a reciprocal BLAST of the putative orthologs also 
identified SPV-1 as the closest relative in C. elegans, We performed a conserved 
domain search and identified that the human orthologs share the same domain 
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architecture as SPV-1. A single study has reported HMHA1 to harbor a BAR domain 
(de Kreuk et al., 2013) while PARG1 and GMIP have yet to be characterized. Next, 
we performed a sequence alignment of the F-BAR domain with the closest ortholog 
of selected organisms at various milestones of the evolutionary tree, and found a high 
degree of conservation of the F-BAR between SPV-1 orthologs of distinct species 
(Figure 20B). To further understand which subfamily of F-BAR domain is SPV-1 
associated with, we performed a phylogenic analysis of the F-BAR domain of SPV-1 
and its human orthologs along with all known F-BAR domains in C. elegans and 
human. As expected, F-BAR domains from the various subfamilies formed individual 
clusters (Figure 20C). Interestingly, the F-BAR domain of SPV-1 and its orthologs 
formed a distinct cluster (Figure 20C), indicating that we discovered a novel 
subfamily of F-BAR domains.   
 
F-BAR domains form homodimers with a characteristic concave-shaped protein 
structure. To identify if the F-BAR domain of SPV-1 takes on this characteristic 
appearance, we modeled the F-BAR domain with I-TASSER (Roy et al., 2010) using 
the 2.4 Å N-terminal crystal structure of GMIP (PDB ID:3QWE) as a template. The 
predicted model has a confidence score of -0.96 (in a scale of -5 to 2)  Figure 20D 
(top panel) shows a side view of the predicted SPV-1 F-BAR domain in dimer form. 
The dimer displays a shallow concave curvature as expected for F-BAR domains. The 
bottom panel, showing the membrane-interacting surface, highlights the clustering of 
positively charged amino acid residues (indicated in blue) reminiscent to the 
characteristics of F-BAR domains. The aggregation of positive charges facilitates 






Figure 20: Bioinformatics analysis of SPV-1. 
(A) Left panel: Protein domain architecture of SPV-1. Right panel: Structure 
prediction of full-length SPV-1. Purple: F-BAR domain, Green: C1 domain, Red: 

























(B) Multiple sequence alignment of the F-BAR domains from a selection of SPV-1 
orthologs. Blue, A, I, L, M, F, W, V, and C; red, R and K; green. N, Q, S, and T; pink, 
C; magenta, E and D; orange, G; cyan, H and Y; yellow, P. Refer to 
http://www.jalview.org/help/html/colourSchemes/clustal.html for the full color 
scheme.   
(C)  Unrooted phylogenic tree depicting human F-BAR domains and selected C. 
elegans orthologs. The F-BAR domain of SPV-1 and its human orthologs 
(HMHA1, GMIP, and ARHGAP29) form a distinct group (gray cloud). Significance 
of each cluster is calcutaed by bootstrap analysis where 100 represents maximal 
suport. ce, C. elegans; hs, H. sapiens.   
(D) Left panel: Ribbon side view of a predicted dimer structure of the F-BAR domain 
of SPV-1. The predicted structure adopts a shallow concave curve. Right panel: The 
membrane-interacting surface is punctuated with positive amino acid residues 
highlighted in blue and negative residues in red. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.8. F-BAR domain of SPV-1 is essential for membrane localization 
 
To experimentally determine the contribution of the F-BAR domain for SPV-1 
membrane localization, we engineered a deletion of the predicted F-BAR domain 
(AA 195 to 405) from the spv-1::GFP construct. As expected, no membrane 
accumulation was observed throughout the course of embryo transit in spv-1 (ok1498) 
mutant worms expressing SPV-1ΔF-BAR::GFP (Figure 21A). In a line profile of 
across a spermathecal cell width, no distinct peak was observed, contrary to those 
from Figure 19A. However, we were unable to obtain transgenic strains with an 
expression level that is comparable to other variants of the spv-1::GFP constructs. 
Absence of membrane localization could be an artifact of low expression levels. A 
possible reason for the low expression could be due to loss of regulatory elements 
within the introns that were removed with the truncation of the F-BAR sequence. To 
circumvent this problem, we replaced the spv-1 promoter with another spermatheca-
specific promoter, sth-1. Even with higher expression, we still did not observe any 
enrichment of SPV-1ΔF-BAR::GFP on the apical membrane throughout the course of 
embryo transit (Figure 21B). This indicates that the F-BAR region is essential for the 
transient translocation of SPV-1 to the membrane.   
 
Interestingly, loss of the F-BAR domain did not hinder the ability of SPV-1 to rescue 
the mutant phenotype in terms of constriction magnitude but prolonged the valve-to-
valve time. The ratio between the distal and proximal width of the spermatheca 
between wild-type, spv-1 (ok1498);spv-1p::SPV-1 and spv-1 (ok1498);sth-1p::SPV-
1ΔF-BAR worms were not significantly different (Figure 21C). Valve-to-valve time in 
the worms carrying the spv-1 (ok1498);sth-1p::SPV-1ΔF-BAR array was slightly but 
significantly elevated compared to wild-type control (p<0.01, n = 26). We attributed 
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the increased valve-to-valve time to over-activation of the RhoGAP activity. Besides 
serving to target SPV-1 the membrane, the F-BAR domain could also act as an auto-
inhibitory signal to prevent excessive RhoGAP activity when SPV-1 is cytoplasmic. 
Hence, loss of the F-BAR domain would result in enhanced RhoGAP activity.  
Indeed, the auto-inhibition between an F-BAR and RhoGAP domain has been 
reported in C. elegans SRGP-1 and also human HMHA-1, one of the human orthologs 
of SPV-1 (de Kreuk et al., 2013; Zaidel-Bar et al., 2010). Unfortunately, our attempt 
to perform a pulldown assay using bacterially synthesized F-BAR and RhoGAP 
fragments of SPV-1 to test for direct interaction was unsuccessful. It will be 
interesting to further investigate if an auto-inhibition between the F-BAR and 





Figure 21: The F-BAR domain of SPV-1 is essential for membrane localization. 
(A) Representative images of SPV-1ΔF-BAR::GFP driven by the spv-1 promoter 
showing its subcellular localization during embryo transit. Graphs show the intensity 
profile of lines drawn perpendicular to the spermatheca cells. Scale bar: whole 
spermatheca – 20 μm; inset – 5 μm.   
(B)  Similar to (A) except for the change to the sth-1 promoter.   
(C) Quantification of the constriction magnitude and valve-to-valve time in SPV-
1::GFP transgenic lines. Data from wild-type and spv-1(ok1498)::spv-1p::SPV-1 were 
duplicated from Figure 9 and Figure 12. Each data point (grey dot) is a single embryo 
transit event. Data are represented by mean ± SEM with n ≥ 23 for each worm strain 
analyzed. Statistical comparisons were performed using one-way ANOVA-Tukey’s 
multiple comparisons test.  
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.2.9. The F-BAR domain of SPV-1 is recruited to the membrane upon 
trypsinization of HeLa cells 
 
To directly test the idea of the F-BAR domain of SPV-1 can respond to changes in 
membrane topology, we expressed F-BAR::GFP in HeLa cells.  We used trypsin to 
stimulate HeLa cell detachment from the membrane and rounding up. A similar 
treatment in CHO cells resulted in formation of nano-membrane curvature upon 
trypsin treatment (Kapustina et al., 2013). In isotonic buffer, F-BAR::GFP was 
observed to be cytoplasmic (Figure 22).  Upon trypsinization and rounding of the 
cells, F-BAR::GFP was seen to gradually accumulate at the plasma membrane. The 
plasma membrane visualized with the membrane dye DiI 561 was largely 
homogenous throughout the trypsin treatment, thus ruling out the possibility that the 
increase in F-BAR::GFP intensity was due to the increase in membrane per unit area. 
Our result implies that the F-BAR domain of SPV-1 is recruited to the region of 
convoluted membrane produced during cell detachment from the substrate, further 
consolidating the fact that the F-BAR domain of SPV-1 acts as a mechanical sensor of 






Figure 22: F-BAR::GFP accumulates at the plasma membrane of upon trypsin 
treatment of HeLa cell. 
Images show the accumulation of F-BAR::GFP at the cell membrane (yellow arrows) 
75 sec after the addition of Trypsin. The reaction was quenched at 145 sec by washing 
out Trypsin to prevent complete dissociation of the cell from the surface. The plasma 




3.2.10. Spatial control of SPV-1 localization is essential for initiation of 
contractility 
 
The evidence thus far suggested that during embryo transit, stretching of the 
spermathecal cells is sensed by the F-BAR domain, leading to detachment of SPV-1 
from the membrane and subsequently increase in RHO-1 activity to initiate 
constriction. To directly test the importance of SPV-1 localization in regulating 
spermathecal constriction, we generated a chimeric SPV-1 ΔF-BAR (PH)::GFP in 
which the F-BAR domain was replaced by a plekstrin homology (PH) domain from 
rat phospholipase C gamma 1 (PLCδ1). Mutant transgenic worms carrying the 
chimeric SPV-1 construct displayed permanent SPV-1::GFP localization on the apical 
membrane (Figure 23A, top and middle panel). Phenotypically, the chimeric worms 
had spermathecae with multiple trapped embryos (Figure 23A bottom panel, and 
Figure 23B). Instead of a single embryo transiting through the spermathecal in 
approximately 6 min, the constitutive membrane-bound SPV-1 spermatheca failed to 
constrict and none of the multiple embryos exited the spermatheca during the 30 min 
imaging period. We postulate the permanent docking of the RhoGAP domain of SPV-
1 at the membrane resulted in constant suppression of RHO-1 activity and thus 
reduced spermathecal constriction, which manifested in trapped embryos. This 
suggests that the detachment of SPV-1 from the membrane functions to initiate 





Figure 23: Transient localization of SPV-1 is essential for embryo exit. 
(A) Representative image of the localization of chimeric SPV-1::GFP. The F-BAR 
domain of SPV-1 was replaced with a PH domain. Top panel indicates SPV-1 GFP 
enrichment at the membrane. Middle panel is the inset from the cropped region.  
Bottom panel illustrates multiple trapped embryos in the spermatheca. Scale bar =20 
μm and 10 μm for the full spermathecal and cropped region respectively. 
(B) Quantification of the maximum number of embryos in the spermatheca during a 
30 min imaging period. Each dot represents an independent experiment. n = 10 for 
each strain. 
 
Reproduced with permission from Tan and Zaidel-Bar (2015).  
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3.3. Identification and characterization of a RhoGEF involved in 
spermathecal constriction. 
 
3.3.1. rhgf-1 loss-of-function rescues the spv-1 (ok1498) overconstriction 
phenotype 
 
The regulation of Rho GTPases occurs in a cycle (Figure 2). The GTPase enhancing 
activity of RhoGAPs is counteracted by GDP to GTP exchange catalyzed by 
RhoGEFs. We sought to identify the RhoGEF(s) involved in counteracting SPV-1 in 
the activation of RHO-1 in the spermatheca. 
 
Since RhoGAPs and RhoGEFs perform opposing roles in regulating RhoA activity, 
we hypothesized that the loss of a spermathecal-associated RhoGEF would alleviate 
the spv-1 (ok1498) mutant phenotype. To this end, we performed an RNAi 
knockdown screen for all 20 C. elegans RhoGEFs in the background of spv-1 
(ok1498) mutant and looked for the rescue of embryo shape defect. The identity of the 
RhoGEFs is listed in Table 6. To score the degree of rescue, we dissected 10 worms 
for each gene knockdown and assessed how many of the worms had a majority of 
‘wild-type’-looking embryos (Table 7). Of the 20 RhoGEFs tested, loss of rho 
guanine nucleotide exchange factor (rhgf)-1 successfully restored the embryo 
morphology for all 10 worms dissected (Table 7, red highlight). Live imaging of 
embryo transit events revealed a rescue of the overconstriction phenotype in spv-1 
(ok1498);rhgf-1(RNAi) spermatheca (Figure 24, n = 4). RHGF-1 has been previously 
reported to function upstream of RHO-1 in the release of acetylcholine at the synapses 
of motor neurons (Hiley et al., 2006). We propose that in the spermatheca, loss of 




Table 6: List of RhoGEF-containing genes knocked down by RNAi feeding in the 


























Table 7: Tabulation of results for embryo shape rescue in spv-1 (ok1498) treated 
with RhoGEF RNAi feeding. 
L4440 empty vector and rho-1-targeting RNAi feeding clones were used as negative 
and positive controls respective. Knockdown of rhgf-1 (highlighted in red) shows 
100% restoration of embryo shape to wild-type dimensions. 
 
Target gene No. of worms with 'WT'-
looking embryos 
L4440 (-ve control) 1/10 


























Figure 24: Loss of rhgf-1 in the spv-1 (ok1498) mutant alleviates 
hyperconstriction in the spermatheca.   
Representative images of embryo transit events in spv-1 (ok1498) mutants treated 
with L4440 empty plasmid (negative control, top panel) and rhgf-1 (RNAi). Complete 
ovulation is referred to as time 0 sec. The precocious and hyperconstricted phenotype 
of the mutant spermatheca is reverted to wild-type phenotype under rhgf-1 (RNAi) 





3.3.2. rhgf-1 loss-of-function results in trapped embryos in the spermatheca 
 
We expected the loss of rhgf-1 to completely abolish the contractile ability of the 
spermatheca since RHO-1 activation would be absent. In wild-type worms, 
knockdown of rhgf-1 for 48 hours showed 60% of ovulation events with incomplete 
embryo exit (n = 5). The incomplete penetrance of the loss-of-function phenotype 
could be due to two reasons: 1) incomplete knockdown of the rhgf-1 mRNA transcript 




3.3.3. RHGF-1 is expressed in the spermathecal cells 
 
A previous study on the transcriptional activity of RhoGEFs in gonadogenesis using 
2.5 kb of the rhgf-1 promoter to drive cytoplasmic GFP reported expression in the L4 
spermathecal epithelium (Ziel et al., 2009). Using the same worm strain, we 
investigated the transcriptional expression of rhgf-1 in the spermatheca of young 
adults. We observed spermathecal expression, with strongest expression at the distal 
end of the spermatheca (Figure 25). This is consistent with the fact the constriction is 





Figure 25: Transcriptional expression of RHGF-1 in the spermatheca. 
GFP expression driven by the rhgf-1 promoter is concentrated in the spermatheca, 




3.4. Proposed mechanism of action 
Our results suggest that RHO-1 is a key regulator of spermathecal contractility. We 
have identified SPV-1 (a RhoGAP domain-containing protein) and RHGF-1 (a 
RhoGEF domain-containing protein) as upstream regulators of RHO-1 in the 
spermatheca. SPV-1 and RHGF-1 function antagonistically to regulate the amount of 
active RHO-1 to ensure proper cycles of constriction and relaxation during embryo 
transit (Figure 23).   
 
We propose that during oocyte entry, the spermathecal cells are stretched, leading to 
SPV-1 detachment from the apical membrane due to unfavorable conditions for F-
BAR binding. Removal of SPV-1 and its RhoGAP domain from the membrane lifts 
the inhibition on RHO-1. Concurrently, we hypothesize that oocyte entry also triggers 
the activation of RHO-1 through the RhoGEF domain of RHGF-1. The reciprocal 
effect of SPV-1 and RHGF-1 during oocyte entry ensures the gradual rise of RHO-1 
and the subsequent activation of LET-502 to initiate spermathecal constriction. We 
propose that upon embryo exit, the spermathecal cells collapse, leading reattachment 
of SPV-1 to the apical membrane and suppression of RHO-1 activity. These events 
together suppress RHO-1 activity, leading to a low constriction state while the 







Figure 26: Model illustrating the mechanism on the regulation of spermathecal 
constriction by the reciprocal activity of SPV-1 and RHGF-1. 
SPV-1 inactivates RHO-1 in a cyclical manner by transiently localizing to the apical 
membrane mediated by its F-BAR domain. When the spermatheca is collapsed, 
presence of membrane folds allows SPV-1 to bind to the membrane, and inactivate 
RHO-1 activity through its RhoGAP domain. Oocyte entry stretches the spermatheca 
cells and straightens out membrane folds. This leads to the detachment of SPV-1 from 
the membrane, thus lifting the inhibition on RHO-1 activity. Concurrently, through a 
yet unknown mechanism, RHO-1 is activated by RHGF-1, allowing active RHO-1 to 
rise beyond the threshold needed to initiate spermathecal constriction. 
 












4.1. Embryo shape has profound consequences for embryonic development 
In spv-1 (ok1498) mutants and spv-1 (RNAi) worms, we reported 41% and 50% 
embryonic lethality, respectively (Figure 11C). Based on expression data and genetic 
analysis, we confirmed the lack of SPV-1 function in the embryo (Figure 12A and 
Figure 13). This raised an interesting question regarding the cause of embryonic 
lethality. By plotting the embryo size against the axial ratio, we observed that 
embryos within the wild-type size range but with an aspect ratio below 1.49 tend to 
arrest prematurely while long embryos (with high aspect ratio) were largely 
unaffected (Figure 11B). This prompts us to hypothesize that embryo geometry is a 
contributing factor in determining the viability of embryos during development. A 
study by Minc et. al. revealed that geometrical constraint is an essential cue for 
positioning the division plane in the development of sea urchin embryos (Minc et al., 
2011). One approach to test if embryonic lethality in the spv-1 (ok1498) mutants and 
spv-1 (RNAi) treated worms were simply due to the fact that embryos were missing 
some cytoplasmic content due to pinching off of the embryos or geometrical 
constraint is indeed contributing to embryonic development is to physically deform 
the embryo shape. Nghe and colleagues described the fabrication of micron-size 
polyacrylamide chambers for confinement of C. elegans larvae (Nghe et al., 2013). 
The advantage of using polyacrylamide in place of the more traditional 
polydimethylsiloxane (PDMS) is the permeability of polyacrylamide to buffered 
solutions to ensure proper development during long term confinement of the worms in 
the chambers (Nghe et al., 2013). Instead of hatched larvae, we propose to culture C. 
elegans embryos in chambers of various geometries to test the contribution of embryo 
shape to development. Polyacrylamide wells of round, elliptical and elongated 
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geometry can be used to deform and constraint embryos during development to 
simulate the condition observed in spv-1 (ok1498) and spv-1 (RNAi) embryos. Indeed, 
deformation of embryo shape using polyacrylamide wells have successfully been 
performed (Pierre Recouvreux, personal communication). The mechanistic 





4.2. Human orthologs of SPV-1  
DELTA-BLAST results revealed that SPV-1 has three human orthologs, namely 
PARG1, HMHA1 and GMIP. From bioinformatic analysis, all three human orthologs 
share the same domain architecture as SPV-1. Of the three orthologs, only HMHA1 
has been characterized to modulate the actin cytoskeleton an cell spreading through 
the regulation of RhoA activity (de Kreuk et al., 2013). The same group also report 
the presence of a BAR domain in HMHA1 which acts as an inhibitor of the RhoGAP 
activity (de Kreuk et al., 2013). PARG1 is known to function as a RhoGAP protein in 
modulating cell shape change but the presence of an F-BAR domain has been 
overlooked (Saras et al., 1997). There has yet to be a published finding on the 
spatiotemporal localization of the SPV-1 orthologs in mammalian cells. A recent 
paper reported a feedback mechanism between plasma membrane tension and the 
activation of an F-BAR-containing protein, FBP17, regulates cell migration (Tsujita 
et al., 2015).  FBP17 localizes to membrane invaginations at the leading edge to 
promote actin polymerization, while diminishing from the cell rear in response to an 
increase in plasma membrane tension. We hypothesize that in mammalian cells a 
mechanism similar to that of SPV-1 in the spermatheca could take place whereby a 
mammalian ortholog of SPV-1 regulates RHO-1 in a membrane curvature-dependent 
manner. Currently, we have an ongoing collaboration with Nils Gauthier 
(Mechanobiology Institute, Singapore) and his group to further elucidate the function 
of PARG1 during cell spreading in mouse embryonic fibroblasts (MEFs) and cell 
migration in mouse mammary epithelial cells (EpH4). We tested the expression levels 
of PARG1, HMHA1 and GMIP in both cell types by detecting the mRNA transcript 
levels using Reverse Transcription and semi-quantitative PCR. PARG1 was found to 
be expressed at the highest level in both cell types (Figure 27). We are currently 
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performing phenotypic analysis and analyzing the spatiotemporal information of full 
length PARG1, PARG1ΔF-BAR and PARG1ΔRhoGAP in MEFs and EpH4 cell lines 






Figure 27: PARG1, GMIP and HMHA1 transcript levels in EpH4 and MEF 
cells. 
Amplification of the PARG1 total cDNA gave distinct bands starting from cycle 32 in 
EpH4 cells and cycle 27 in MEF cells. GMIP transcript is only present in EpH4 cells 
while HMHA1 is not expressed in both cell types tested. GAPDH is used as a 
housekeeping control.  
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4.3. The F-BAR domain of SPV-1 and its orthologs form a novel subfamily 
In a phylogenic analysis, we discovered that the F-BAR domains of SPV-1, along 
with its human orthologs, PARG1, GMIP and HMHA1, formed a distinct cluster 
separate from currently known human F-BAR domains (Figure 20C). Besides the 
divergence in sequences of the F-BAR domain of SPV-1 with other F-BAR 
subfamilies, SPV-1 did not generate tubules when overexpressed (Figure 28), as is 
usually the case with other F-BAR domain subfamily proteins (Heath and Insall, 
2008; Tanaka-Takiguchi et al., 2013; Zaidel-Bar et al., 2010). It will be interesting to 
test if the F-BAR domain of SPV-1 and its human orthologs are capable of inducing 
the formation of tubules in either mammalian cells or liposomes as was shown for the 
F-BAR domain of FBP17 and CIP4 (Frost et al., 2009; Tanaka-Takiguchi et al., 
2013). If indeed the F-BAR domain of the SPV-1 family is unable to tubulate 
membranes, it makes this noval family of F-BAR domains unique in that it solely 
functions to sense and bind to membrane with suitably curved surfaces. It will be 
interesting to identify the differences in structure or amino acid sequences that 
distinguish between the curvature-sensing or membrane-tubulating properties of the 






Figure 28: No observable membrane invaginations in the spermatheca of SPV-
1::GFP transgenic animals. 
No discernable differences between the apical membrane of SPV-1::GFP expressing 
in the spv-1(ok1498) or overexpression of SPV-1::GFP in the wild-type background. 





4.4. Autoinhibition of SPV-1 
Our results suggest that the activity of the RhoGAP domain is autoinhibited by its F-
BAR domain when SPV-1 is cytoplasmic. Although we were unable to show a direct 
binding between the RhoGAP and F-BAR domains, we cannot rule out that the 
inhibition is a result of conformational change and steric hindrance. Indeed, there 
have been several reports on autoinhibition of the RhoGAP domain by a BAR domain 
(de Kreuk et al., 2013; Galic et al., 2014; Zaidel-Bar et al., 2010). One approach to 
test for autoinhibition of the RhoGAP activity would be to perform a RhoGAP assay 
and compare the GAP activity of full length SPV-1 with only its RhoGAP domain. 
However, a limitation of an in vitro assay is the requirement of purified proteins. The 
large size of SPV-1 protein (966kDa) could prove difficult to express and purify.  
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4.5. Alternative hypothesis for SPV-1 mode of action 
We hypothesized that the F-BAR domain of SPV-1 serves two roles: 1) to release the 
inhibition on the RhoGAP domain when SPV-1 is targeted to the membrane, and 2) to 
physically target the RhoGAP domain at the membrane for the inactivation and 
hydrolysis of Rho-GTP to Rho-GDP. Since active RHO-1 is localized to the plasma 
membrane, we hypothezise that the physical presence of the RhoGAP domain of 
SPV-1 at the membrane is essential for the hydrolysis of active RHO-1. However, our 
results showed that while loss of the F-BAR domain from SPV-1::GFP abolished its 
membrane-targeting ability, the truncated protein was still able to rescue the mutant 
phenotype. This raised two possibilities: 1) membrane-targeting ability of SPV-1 is 
dispensable for its function as a negative regulator of RHO-1 activity, or 2) although 
SPV-1 is no longer visibly enriched at the membrane, a percentage of SPV-1 is still 
able to exert its RhoGAP activity on RHO-1 at the membrane by relocating to the 
plasma membrane through passive diffusion. Our results suggest that the latter 
explanation is more probable due to the fact that permanently docking SPV-1 to the 
membrane using a PH in place of the F-BAR domain resulted in a non-contractile 
spermathecae, indicating that localization of the RhoGAP domain at the membrane is 
essential for functionality of the RhoGAP domain. To experimentally test if 
cytoplasmic RhoGAP domain of SPV-1 is capable of regulating RHO-1 activity, we 
suggest replacing the F-BAR domain with amino acid residues 231-360 of Listeria 
monocytogenes ActA. The mitochondria-targeting sequence has been reported to to 
bind to the outer mitochondria membrane (Bear et al., 2000) and could act to prevent 
SPV-1 to be in close proximity with the plasma membrane. This could directly test if 
cytoplasmic SPV-1 could result in RHO-1 inactivation, hence highlighting the 
importance of an F-BAR domain to transiently locate SPV-1 to the membrane.  
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4.6. Changes in membrane topology with SPV-1 translocation 
We hypothesize that the release of an oocyte into the spermatheca results in the 
stretching of spermatheca cells, flattening of membrane folds, and detachment of 
SPV-1 from the membrane. On the contrary, exit of the newly fertilized embryo from 
the spermatheca would lead to the collapse of the spermatheca pouch, reformation of 
membrane folds, and recruitment of SPV-1 to the membrane. Although the 
convoluted membrane of the spermatheca during the resting stage has been 
documented using EM, the dynamic change on the membrane topology during 
embryo transit is currently unknown. Performing EM imaging on an embryo-filled 
spermatheca during would reveal the difference in membrane topology between the 
‘empty’ and ‘filled’ spermatheca state. However, EM imaging is unable to capture the 
dynamic changes in the membrane properties during embryo transit to correspond 
with the gradual detachment of SPV-1 from the membrane. Furthermore, we were 
unable to visualize the recruitment of SPV-1 back to the membrane upon embryo exit 
as the collapsed spermatheca hindered viewing of the apical membrane. To indirectly 
show the recruitment of SPV-1 to the plasma membrane upon embryo exit, we 
utilized a heterologous system whereby the F-BAR domain of SPV-1 was expressed 
in HeLa cells. Formation of membrane convolution has been report for CHO cells 
upon trypsin treatment (Kapustina et al., 2013). We successfully demonstrated that F-
BAR::GFP is recruited to the plasma membrane of HeLa cells upon trypsinization. 
However, we did not observe the reattachment and spreading of HeLa cells in the 
immediate timepoint post-trypsin treatment, hence we were unable to observe the 
detachment of the F-BAR domain from the membrane. An alternative method to 
directly test the curvature-sensing ability of the F-BAR domain, we propose to modify 
the cell area or cell volume as a means to alter membrane topology. Mouse embryonic 
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fibroblasts (MEFs) have been shown to modulate its cell membrane properties upon 
stretching or change in osmolarity (Kosmalska et al., 2015). Similar approach can be 
adapted for cyclical modification of the HeLa cell membrane to mimic spermathecal 




4.7. Proposed mechanical regulation of RHGF-1 in the spermatheca 
Previous reports have identified LARG as the human ortholog of RHGF-1 (Shaye and 
Greenwald, 2011; Ziel et al., 2009). Studies on human LARG described activation of 
RhoA downstream of LARG following mechanical stretching (Abiko et al., 2015; 
Guilluy et al., 2011; Lessey-Morillon et al., 2014). We hypothesize that a similar 
mechanism could be at play in the spermatheca, whereby oocyte entry serves as a 
mechanical signal to initiate RHO-1 activation through RHGF-1. LARG has been 
reported to be recruited to focal adhesions upon tensional force applied to the integrin 
receptors (Guilluy et al., 2011). Integrin receptors are heterodimers composed of 
alpha and beta subunits. In C. elegans, structures analogous to focal adhesions are 
termed dense bodies and have mostly been studied in the connection between muscle 
cells and the extracellular matrix (Lecroisey et al., 2007). C. elegans has two alpha 
integrin subunit orthologs: ina-1 (Baum and Garriga, 1997) and pat-2 (Williams and 
Waterston, 1994), and a single beta subunit ortholog: pat-3 (Gettner et al., 1995; 
Williams and Waterston, 1994). The presence of pat-3 has been observed in the 
spermatheca from MH25 anti-pat-3 antibody staining as a weak and diffusive pattern 
(Kovacevic and Cram, 2010). Using a worm strain expressing PAT-3::GFP, we 
identified expression in the spermatheca, which localized to the basal membrane of 
the spermathecal cells (Figure 29A). We have also successfully observed INA-1::GFP 
in the spermatheca, although the expression was more diffused (Figure 29B). Taken 
together, the presence of integrins in the spermatheca is consistent with the hypothesis 
that during embryo transit, mechanical stretching of the spermathecal cells could be 
transmitted through INA-1, PAT-3 and possibly PAT-2 and leads to the recruitment 
and activation of RHGF-1 to initiate downstream constriction events through the 
RHO-1/LET-502 signaling pathway. It will be interesting to knockdown C. elegans 
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integrins in the spv-1 (ok1498) background to determine if loss of the integrin 
components would reduce RHO-1 activation hence rescue the hypercontractile 






Figure 29: Expression pattern of C. elegans integrins in the spermatheca. 
(A) PAT-3::GFP expression is enriched at the basal membrane of the spermatheca 
(arrows). Scale bar = 20µm. 





4.8. Additional RhoGEFs that may function in parallel with RHGF-1 to 
activate RHO-1  
Since the spermatheca still retained a weak contractile ability with rhgf-1 knockdown 
(Figure 21), it is highly probable that rhgf-1 is not the sole activator of RHO-1 during 
embryo transit. From the results of RNAi knockdown of RhoGEFs in the background 
of spv-1 (ok1498) (Table 5), both Y105E8A.25 and unc-73 scored 7/10 in the number 
of worms with embryos resembling wild-type morphology, which gave an indication 
that both genes could be involved in the regulation of RHO-1 activity in the 
spermatheca alongside rhgf-1. However, we were unable to reproduce the rescue of 
spv-1(ok1498) spermatheca overconstriction by unc-73 RNAi knockdown. 
Henceforth, we shall continue to characterize Y105E8A.25.  One approach to test for 
redundancy is to perform a double knockdown of rhgf-1 with Y105E8A.25. We 
should expect a severe embryo trapping phenotype resulted from a further depletion 
of RHO-1 if Y105E8A.25 is indeed demonstrating RhoGEF activity in the 
spermatheca. Y105E8A.25 is an uncharacterized protein with no known protein 
domains apart from the RhoGEF domain. Generation of a reporter strain and a null 





4.9. Interplay between RhoA and the calcium signaling pathway in 
contractile regulation of an epithelial tube. 
The myoepithelial pouch that forms the C. elegans spermatheca is highly analogous in 
terms of structure and function to contractile smooth muscle tubes such as blood 
vessels, respiratory tract and salivary ducts in mammals. Abnormal smooth muscle 
contractions in these tissues result in severe pathological conditions such as asthma 
and hypertension. Both RhoA and calcium signaling have been shown to be essential 
for the constriction of airway smooth muscle cells and blood vessels (Chiba and 
Misawa, 2004). Although, these two pathways have long been established, they are 
usually identified as two independent pathways, converging at the level of myosin 
light chain phosphorylation. Kovacevic and colleagues reported a correlation between 
mechanical stretching of the spermatheca during oocyte entry and a rise in calcium 
levels to initiate spermathecal constriction and embryo exit (Kovacevic et al., 2013). 
The oocyte entry-dependent calcium release is regulated by PLC-1 and its 
downstream partners. They postulated that PLC-1 could be under the regulation of 
RHO-1, as suggested by studies conducted in mammalian cells (Wing et al., 2003). 
An ongoing collaboration with the Cram lab (Northeastern University, Boston, MA) 
is focused on characterization of the calcium activation profile in worms depleted of 
spv-1 and rhgf-1 and performing spatio-temporal correlation between RHO-1 activity 
and the calcium levels in the spermatheca. Preliminary findings indicate that calcium 
level is elevated precociously in the spv-1 (ok1498) mutant, indicating RHO-1 to 
function upstream of PLC-1-mediated calcium release. However, truncation of the 
RHO-1-binding site in PLC-1 did not affect calcium levels, suggesting an indirect 




4.10. Mechanical changes in the spermatheca during embryo transit 
Although a dramatic physical change in cell shape is observed in the spermathecal 
during embryo transit, changes in membrane tension of the spermathecal cells have 
not been measured.  Based on the transient membrane localization of SPV-1, we 
hypothesize that the loss of membrane curvature during embryo transit could 
correspond with increase in membrane tension. Laser microsurgery is an established 
method for estimating forces in and between cells to better understand tissue 
mechanics and morphogenesis (Rauzi and Lenne, 2011). Laser ablation experiments 
could serve as a tool to quantitatively compare between the mechanical forces 
involved during the various stages of embryo transit. An alternatively approach could 
be the use of a FRET-based tension sensor that incorporates a tension sensing module 
into the coding sequence of the unc-70 gene which has been recently optimized for 
detection of mechanical tension in C. elegans (Kelley et al., 2015). Together, these 
data would give us a better understanding of the mechanical properties of the 




4.11. Spatio-temporal regulation of RhoA activation 
 
RhoA-mediated signaling can stimulate opposing cellular processes. For example, 
RhoA is required to promote junction formation and apical constriction, but is also 
essential for weakening of cell adhesion and preventing cell spreading (Etienne-
Manneville and Hall, 2002; Terry et al., 2010). In migrating fibroblast cells, RhoA 
has been documented to be active simultaneously at the leading edge of protruding 
lamellae and also the rear during tail retraction events (Pertz et al., 2006). Hence, the 
activation of RhoA has to be coordinated in space and time to restrict its activity at 
discrete subcellular location for the regulation of specific cellular processes.   
 
The diversity of RhoGEF and RhoGAP proteins far outnumber the RhoGTPases.  
This discrepancy could prove to be an evolutionary advantage for a more precise 
regulation over the activity of RhoGTPases. One strategy for spatial control of RhoA 
activation is to have the Rho regulators occupying distinct intracellular niches within 
the cell. At the epithelial junction, RhoA is essential for the formation and 
maintenance of the tight and adherens junctions mediated by the actomyosin 
cytoskeleton (Nusrat et al., 1995; Yamada and Nelson, 2007). p114RhoGEF is a tight 
junction-associated RhoGEF that regulates epithelial junction assembly through 
spatially-localized activation of junctional RhoA (Terry et al., 2011). During 
collective migration in bronchial epithelial cells, the RhoGAP protein Myosin-IXA is 
spatially recruited to nascent adhesion sites and temporarily limits RhoA-mediated 
contractile forces during the early stages of cell-cell contact formation (Omelchenko 
and Hall, 2012). These examples demonstrate the precise targeting of RhoA 




In addition to spatial regulation, activation of RhoA also needs to be temporally 
coordinated. For example, RhoA activity is elevated by an internal signal during onset 
of mitosis to mediate cell rounding and stiffening of the cell cortex (Maddox and 
Burridge, 2003). Upon mitotic onset, phosphorylation and activation of the RhoGEF 
Ect2, combined with the phosphorylation and inactivation of GAP p190RhoGAP, 
results in a global increase in RhoA activity (Maddox and Burridge, 2003; Matthews 
et al., 2012). Several lines of evidence have also described the temporal regulation of 
RhoGEFs and RhoGAPs in response to external stimuli. Phosphorylation and 
activation of the RhoGEF vav2 upon cyclic stretching has been reported in mesangial 
cells (Peng et al., 2010) while shear stress in the endothelial cells regulate p190GAP 
activity in a biphasic manner (Yang et al., 2011). 
 
Our findings on the membrane-curvature-mediated relocalization of the RhoGAP 
SPV-1, together with its counterpart RhoGEF RHGF-1, provide further insight on the 
mechanism governing spatio-temporal control of RhoA regulation in the context of 
cyclical regulation of a contractile tube. The regulation of RhoA activity will directly 
impact the activity of Rho kinase in the phosphorylation of MLC, thus affecting 
contractility of smooth muscle cells in an epithelial tube setting. Furthermore, 
evidence for mammalian cell studies have proposed RhoA to function upstream of 
PLC-1 and calcium release in the regulation of smooth muscle contractions. Hence, 
our study on the membrane curvature-dependent translocation of SPV-1 as a means to 
regulate RhoA activity provides a novel understanding to how the cyclical regulation 




4.12. Signaling downstream of BAR domain curvature sensing 
Members of the BAR domain superfamily are capable of sensing and binding to 
plasma membrane of distinct curvature. Isolated N-BAR domains of nadrin 2 and 
amphiphysin 1 have been demonstrated to be selectively recruited to membrane folds 
artificially generated by nanocones (Galic et al., 2012). The BAR domain family of 
proteins are functionally diverse as they are coupled to a wide variety of accessory 
domains (Peter et al., 2004). The selective membrane binding property of the BAR 
domains make them suitable candidates for spatio-temporal targeting of their partner 
domains to membrane sites during dynamic remodeling of the plasma membrane. The 
migratory cell front demonstrates an oscillatory protrusion-retraction cycle. FBP17, 
an F-BAR domain-containing protein, is specifically recruited to membrane 
invaginations at the leading edge of COS-7 cells to promote actin polymerization and 
protrusion formation. Formation of actin protrusions results in detachment of FBP17 
from the membrane, providing a reciprocal feedback regulation on the formation of 
the leading edge during cell migration (Tsujita et al., 2015).  
 
A subset of BAR domain family proteins is associated with RhoGEF or RhoGAP 
domains (Peter et al., 2004). ArhGAP44 possesses an N-BAR and RhoGAP domain.  
During neuronal development, ArhGAP44 is recruited to inwardly deformed plasma 
membrane sections to limit filopodia formation by local inhibition of Rac activity 
(Galic et al., 2014). Our results provide another example of how an F-BAR domain 
acts a mean for sensing of mechanical changes in the membrane property and the 












Conclusion & Perspectives  
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5. Conclusion and Perspectives  
 
5.1. Universal mechanism in the cyclical regulation of contractility 
In this study, we have identified two novel regulators of RHO-1 activity in the C. 
elegans spermatheca. Our findings describe the reciprocal function of SPV-1 (a 
RhoGAP-domain protein) and RHGF-1 (a RhoGEF-domain protein) in the cyclical 
regulation of spermathecal constriction. We proposed that SPV-1 acts as a 
mechanotransducer to relay the change in spermathecal membrane curvature during 
oocyte entry to biochemical signals to regulate RHO-1-mediated actomyosin 
contractility in the spermatheca. During oocyte entry, stretching of the spermathecal 
cells result in the detachment of the curvature-sensitive F-BAR domain of SPV-1 
from the membrane. This removes the RhoGAP inhibition on RHO-1 activity. On the 
flip side, our results suggest RHGF-1 as a positive regulator of RHO-1 activation to 
counteract SPV-1 activity. Although our study focused on the mechanical regulation 
of RHO-1 activity in a contractile tube, similar mechanisms could be at play in other 
biological systems that display a biphasic pattern of RhoA activity. The plasma 
membrane is common to all cells, and could act universally as a site of 
mechanotransduction. Hence, the direct feedback mechanism we elucidated between a 
physical signal of membrane curvature and the biochemical cascade leading to 
actomyosin contractility could be crucial in many other cellular and tissue processes 
involving cell deformation, ranging from cell motility to tissue morphogenesis and 
wound repair.  
113 
 
5.2. Upstream regulators of RhoA as drug targets for diseases of the 
epithelial tubes  
Due to the diverse roles of RhoA, it is unsurprising that its misregulation is associated 
with the pathogenesis of a large number of human diseases. Hence, regulation of 
RhoA and its downstream effectors is a popular strategy for treatment (Barman et al., 
2009; Gur et al., 2011; Kume, 2008; Molli et al., 2012). In pulmonary arterial 
hypertension, elevated levels of RhoA activation in vascular smooth muscles was 
found to cause arterial constriction and remodeling of the vascular walls. Therefore, 
one therapeutic approach is through inhibition of the RhoA pathway (Antoniu, 2012). 
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